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Abstract 
Breast cancer is one of the most common causes of cancer death in women, and 
approximately one in ten women is diagnosed. Reliable and timely diagnosis of breast cancer 
is of paramount importance in its successful treatment. There are several diagnostic 
techniques to detect and characterise breast lesions, including biopsy, X-ray mammography, 
ultrasound and magnetic resonance imaging (MRI). Currently, the gold standard in breast 
cancer diagnosis is biopsy. Ultrasound is the most readily accepted tool in differentiating a 
simple cyst from a solid lesion. In 1984, Christian Langton developed an advanced 
quantitative tissue assessment technique, Broadband Ultrasound Attenuation (BUA), 
dependent upon both density and structure. This thesis describes the further development of 
BUA, specifically the development and validation of 3D tissue assessment utilising a pulse-
echo phased-array flat-bed scanner. This portable, non-ionising and low-cost system for the 
assessment of breast health can acquire 3D data for a whole breast in three minutes from a 
series of 2D image slices. This study is also aimed at developing a technique that will allow 
tissue characterisation for potential early detection of breast cancer. Short time Fourier 
transform (STFT) was applied to the signals and BUA of the ultrasound beams and was 
tested and validated using the scanner and breast phantom with attenuation coefficients 
within the range of 0.1–1.5 dB/MHz/cm. The measurements were performed with two 
different broadband transducers—2.25 and 5 MHz. Several reconstruction software systems 
were tested and validated to produce 3D broadband ultrasound attenuation (BUA) that can be 
used to differentiate cystic lesions from breast lesions. Promising results were obtained for 
differentiating solid lesions from cystic lesions using the BUA analysis that could provide 
useful diagnostic information. The 2.25 MHz phased-array transducer demonstrated BUA 
value of 0.74 +/- 0.09 dB/MHz/cm that indicated the presence of solid lesions. The 5 MHz 
phased-array transducer demonstrated BUA values of 0.51 +/- 0.09 dB/MHz/cm that 
indicated the presence of solid lesions, and no cystic lesions were shown. This BUA analysis 
would enable better interpretion of conventional ultrasound imaging, because the BUA 
analysis can detect only solid lesions that cause high attenuation of the signal.  
Studies using a flat-bed scanner with 2.25 and 5 MHz transducers have shown that the 5 MHz 
transducer had better spatial resolution with stronger echo for several features of the phantom 
compared with 2.25 MHz transducer. It was also shown that 2.25 MHz transducer showed 
more deep penetration ultrasound that showed more information of deep near field objects 
 xvii 
 
and deep cystic objects. A Voluson scanner with 11 MHz linear transducer was used to 
compare and study spatial resolution and spatial accuracy of the flat-bed scanner. The 
experimental results using a wire phantom demonstrated that the flat-bed scanner was better 
in term of penetration and showed more image details. This is because the flat-bed scanner 
utilises a broadband transducer with centre frequencies of 0.5–5 MHz, incorporating the 
benefits of higher and lower frequencies and subsequently improving the quality of the 
image, whereas the Voluson scanner utilises only one operating frequency. However, the 
axial and lateral resolutions of the GE Voluson were better than the flat-bed scanner, since 
the axial and lateral resolution were 0.17 mm and 0.5 mm against 0.31 mm and 1 mm 
respectively. In addition, the experimental results of 3D spatial accuracy using breast 
phantom showed that the flat-bed is sensitive to similar structures as the Voluson scanner, 
and solid lesion volumes can be quantified.  
The findings of this study should prove useful for the early detection of breast cancer. We 
also believe that placing a flexible mesh slightly under the water level will provide a means 
of reliable ultrasound coupling and a support for the sample. This approach will remove the 
requirement for conventional gel coupling.  
In this thesis, novel software based on short-time Fourier transform is developed and 
scientifically validated using ultrasound needle breast biopsy phantom with amorphous 
lesions from CIRS that produces 3D BUA mapping of breast lesions, which can be used for 
differentiating a simple cyst from a solid lesion. It can also be used to produce a 3D BUA 
image of solid lesions using a flat-bed scanner, based on a variable frequency pulse-echo 
ultrasound.  
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1.1. Introduction 
1.2. Research Aim 
This project aims at investigating the utility of quantitative 3D ultrasound (Q3D) in the 
characterisation of breast cancer using novel multi-frequency 3D pulse-echo technology, 
using a flat-bed ultrasound scanner. The project examines the positioning of a flexible mesh 
that is acoustically transparent within the water bath, providing it with reliable means of 
ultrasound coupling that supports the establishment of the sample. 
1.3. Research Objectives 
The fundamental aim of this project is to develop and validate a novel quantitative 3D 
ultrasound measurement technique. The flat-bed ultrasound scanner is based on the Olympus 
Omniscan industrial ultrasound test unit.  
1.4. Research Hypotheses  
The first hypothesis: It is technically feasible to develop a quantitative 3D broadband 
ultrasound technique using the flat-bed ultrasound scanner with 2.25 and 5 MHz transducers 
that provides scientifically relevant information on the status of breast lesions. In addition, 
this technique can provide more information about the investigated phantom than can the 
clinical ultrasound scanner with a linear 11 MHz transducer.  Since the flat-bed device adopts 
the BUA technique that can provide more information such as breast structure. It would be 
relevant to note here that a conventional Voluson scanner with 11 MHz transducer was 
chosen because a 2.5-5 MHz clinical scanner was not available. 
The second hypothesis: BUA is not sensitive to frequency-independent attenuation 
mechanisms such as reflection and refraction.  Since the attenuation (dB/MHz) can be 
calculated by the slope of the linear regression between attenuation (dB) and frequency 
(MHz).  
1.5. Research Questions 
Is it possible to develop a quantitative 3D broadband ultrasound technique that can provide 
relevant information on the status of breast lesions and more information of the breast lesions 
than the clinical ultrasound scanner provides? Using ultrasound needle breast biopsy phantom 
(developed by Computerised Imaging Reference System, CIRS, USA) that accurately 
replicates the ultrasonic characteristics (i.e. attenuation & velocity of sound) , it is envisaged 
that similar findings would be observed in natural breast tissues.    
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The findings of this thesis are expected to provide scientific validation for the differentiation 
of cystic and solid breast lesions.  The thesis will contribute underpinning work to eventually 
enable these tissue-related issues to be addressed.  
Can a software be developed to automatically detect and identify different types of breast 
lesions ? 
Is there a linear relationship between attenuation (dB) and a range of frequencies (MHz) for a 
particular tissue?  
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1.6. Background 
Breast cancer is one of the most widespread causes of death in women [5]. According to 
current research, cancer is diagnosed in approximately one in every ten women. The reliable 
and timely diagnosis of breast cancer can have a significant effect on treatment.  
There are diverse diagnostic techniques for detecting and categorising breast cancer, for 
example, biopsy, X-ray mammography, ultrasound and magnetic resonance imaging (MRI). 
The current gold standard in breast cancer diagnosis is biopsy. Studies show that 68–87% of 
biopsies yield negative results [6]. In addition, this is an invasive technique that necessitates 
surgical removal of tissue samples from the patient, and it is a time consuming process, 
requiring days to weeks to obtain results. 
X-ray mammography is the most widely used method for the detection of breast cancer. X-
ray mammography is a noninvasive technique that can distinguish breast cancer from small 
lesions as well as masses palpated during physical examinations and that can also detect 
ductal carcinoma in situ (DCIS) [7]. However, x-ray mammography has a 10% rate of false 
negative results [8]. While a false positive rate in x-ray mammography varied from 8% to 
21% [9]. The development of cancer sometimes goes undetected because of inadequate 
sensitivity and limited resolution of the technique. 
MRI is used for women with a high risk for breast cancer. In addition, many studies have 
demonstrated that MRI can be used as an additional technique to determine the extent of 
cancer using gadolinium enhancement, once breast cancer has been detected. Invasive breast 
cancers show better images after injection of contrast enhanced MRI gadolinium. Some 
clinicians use it to determine the stage cancer. Although the sensitivity of MRI is high, the 
specificity is moderate to low, and the technique is expensive [10].   
Conventional ultrasound based on 2D imaging has been used as an additional characterisation 
technique after x-ray mammography. The ultrasound diagnosis aims at evaluating palpable 
masses and is considered to supplement mammography.  
Ultrasound has several advantages over X-ray mammography. It is more sensitive than 
mammography for dense breast tissue. Besides, it is recognised as the most readily accepted 
tool in differentiating a simple cyst from a solid lesion [11-14]. Breast ultrasound can be used 
to detect a cystic mass as small as 1–2 mm with 100% specificity [15]. Furthermore, 
quantitative ultrasound (QUS), such as the broadband ultrasound attenuation (BUA) method, 
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can provide not only structural/volume information, but also information regarding tissue 
content [16]. 
The aims of this project are to develop and validate a new 3D quantitative ultrasound 
assessment of breast lesions using novel variable-frequency 3D pulse-echo technology using 
a flat-bed ultrasound scanner that allows us to scan a breast phantom in order to acquire 
mostly consistent 3D data of slices of both A-scan and 2D B-scan. The A-scan and 2D B-
scan can be used to perform quantitative ultrasound assessment of breast lesions that could 
differentiate malignant from benign lesions. A-scans will be processed to perform 3D BUA 
(dB/MHz) mapping of breast lesions, and B-scans will be processed to measure breast lesion 
volumes.  
There are several methods for calculating the attenuation of the ultrasound. These include the 
power law of scattering, specular reflections, bandwidth of the incident pulse and the 
transmission of the central frequency [17, 18]. Fourier transmission, a common method of 
estimating attenuation, uses ultrasound signals in derivation of the spectra amplitude and the 
phase of approximation to measure the reduction and dispersion of the medium. Zhao et al.’s 
method [4], based on the time-frequency study, identifies STFT in approximation of the 
ultrasonic attenuation. In this method, the amplitude of the signal spectra is calculated using 
short time intervals at a certain frequency. The reduction coefficient, obtained through the 
calculation of the amplitude of the pulse spectrum, ensures maintenance of the same time-
domain at different frequencies. This technique depends on approximation of the ultrasound 
attenuation that is minimised through computing the pulse spectrum amplitude that decays 
with time. The new projected method of BUA proposed in this thesis also has an 
approximation based on STFT.  
This technique uses the flat-bed scanner, based on the Olympus Omniscan industrial phased-
array test unit with the 128-element broadband phased-array transducer, to measure the 
volume of the breast lesions and spatial accuracy of the scanner. This scanner uses pulse-echo 
technology to scan a phantom mechanically in order to acquire 3D data of slices of 2D B-
scan of the phantom. It can provide 3D data of the entire phantom in approximately three 
minutes. These 3D data of slices of 2D images can be processed to segment and quantify 
regions of interest, like lesions, using the Simpleware program. Simpleware is used for image 
processing using the datasets from the scanner to create a 3D model of the breast lesions. In 
addition, Simpleware can be used to differentiate cysts from solid lesions.  
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The advantage of this new method is that it utilises a range of frequencies of the phased-array 
broadband transducer that help obtain a more comprehensive picture of the breast lesions. 
The findings of this project can be expected to improve the early detection of breast cancer.  
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2.1. Literature Review  
 
2.2. Medical Motivation 
As mentioned in the previous chapter, breast cancer is one of the most common causes of 
cancer death in women [5], and approximately one in ten women are diagnosed. Although it 
can affect women of all ages, it is diagnosed less frequently in women under the age of 30 
[5]. Breast lesions comprise haematomas, inflammation and abscesses. A haematoma is a 
collection of blood outside the blood vessels within the tissues. The inflammation consists of 
modifications, which are known as fibrocystic diseases of the breast, such as enlargement of 
the ductal network (duct ectasia), changes in the shape or size of ducts or lobules (mammary 
dysplasia), abnormal growth of cells from ducts or lobules (hyperplasia) and formation of 
cysts, which are sacs or capsules that contain a liquid or semi-solid material [10]. Abscesses 
consist of tumours, which are malignant cancer (carcinomas) formed by abnormal and 
uncontrolled cell growth [10]. The danger with this uncontrolled cell growth and large 
tumour is that the cells can invade deeper and spread through the body, where new tumours 
begin to develop, known as metastasis [10].  
Sensitivity and specificity analysis may be performed to assess the benefits and limitations of 
breast cancer imaging. The sensitivity of diagnosis measures the percentage of breast cancer 
correctly identified when breast cancer is present. Several factors play a role in the sensitivity 
of mammography, such as lesion conspicuity, lesion size, breast tissue density, patient age, 
hormone levels, overall image quality and the interpretive skill of the radiologist [19]. High 
sensitivity results in few false negative results. Specificity measures the probability of the 
examination being normal when cancer is absent; thus, high specificity also results in few 
false positive results.  
X-ray mammography utilises ionising radiation to image breast tissue; the procedure is 
performed by compressing the breast firmly between a plastic plate and an X-ray cassette that 
contains special X-ray film. Contrary to general X-ray diagnosis procedures, mammography 
utilises relatively low-energy radiation. X-ray mammography is used extensively for 
detecting breast cancer at an early stage and at small sizes that can be treatable. Besides, it 
also evaluates abnormalities examined clinically. However, it is less useful in differentiating 
malignant from benign lesions [10]. There is a significant rate of false negative and false 
positive results in X-ray mammography. It has been reported that the sensitivity of X-ray 
mammography varies from 54% to 58% in women younger than 40 years of age, and from 
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81% to 94% in women older than 65 years of age [20, 21], with an overall sensitivity of 
approximately 75% [22]. Mammography, therefore, has less sensitivity in women aged 40–49 
years than in older women (Figure 2.1). 
 
Figure 2.1: Shows four images for a 44-year-old-woman with a solid lesion in the right 
breast due to class II invasive ductal carcinoma, which is best characterised with MR 
imaging. (a) Mediolateral oblique mammograms show dense parenchyma with focal 
asymmetry, indicating that it is palpable with a radiopaque marker. (b) Radial sonogram 
using L13–7-MHz transducer of palpable mass in 9 o’clock position in right breast shows 
hypoechoic ill-defined margin mass with posterior enhancement, diagnosed as solitary cancer 
with surrounding heterogeneous echotexture. (c) Transverse MIP of subtracted MR image 
obtained three minutes after contrast agent injection shows linear clustered enhancement 
(arrowheads) extending anterior and posterior to the known invasive cancer, due to DCIS 
(ductal carcinoma in situ) (extensive intraductal component). (d) Second-look sonogram in 
radial orientation demonstrates hypoechoic mass with duct extension (arrowheads) and small 
adjacent hypoechoic masses (arrows) due to EIC. Patient opted for mastectomy (2004 Berg et 
al. [1]). 
 
Mammography of high-density tissue is associated with lower sensitivity, with sensitivity 
varying from 30% to 40%. Mammographic sensitivity in dense and heterogeneously dense 
breasts varies from 30% to 48% of cancers diagnosed in extremely dense breasts [1]. The 
poor sensitivity of mammography is mainly due to poor imaging of dense tissue and the 
inability to detect early signs of abnormality. However, the statistics regarding sensitivity and 
specificity indicate more difficulties [6]. The high rate of unnecessary biopsies not only 
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causes a great deal of anxiety and discomfort for millions of women, but also has a huge 
economic cost as well [23].  
MRI is used as an additional evaluation in breast imaging. It uses a powerful magnetic field 
and radio frequency pulses to create images. MRI scanners use a double coil to allow 
simultaneous comparison between the two sides. Breast lesions are characterised based on 
their T1 and T2 signal intensity values [10]. Breast lesions are usually characterised after 
injection of a contrast-enhanced MRI medium through a vein in the hand or forearm. The 
patient lies face down on a platform designed for the examination that can slide into the MRI 
scanner [24]. The platform has cushioned openings to house the breast without compression. 
The examination most often takes an hour, but it can take longer. MRI is used to create 
images of the breast in women at high risk for breast cancer. It can also be used to determine 
the extent of cancer, and sometimes detects lesions hidden from mammography.  
MRI breast cancer screening shows high sensitivity in 95% of invasive ductal carcinoma, 
96% of invasive lobular carcinoma (ILC) and 89% of ductal carcinoma in situ [1]. A previous 
study determined that the sensitivity of mammography, ultrasound and MRI were 33%, 33% 
and 100%, respectively, in screening high-risk women [25]. Overall sensitivity of all 
modalities varies from 33% to 100%. Another study [26] showed that MRI breast cancer 
screening was better at diagnosing tumours in women at increased risk for breast cancer 
because of genetic factors, with a sensitivity of 79.5% compared with 17.9% for clinical 
breast examination and 33% for mammography. On the other hand, researchers found that 
MRI was less specific than mammography in determining which tumours were cancerous 
(90% versus 95%). If specificity is low, several false-positive examinations will result in 
unnecessary intervention. Although the MRI test is very sensitive, it is not a viable option for 
breast cancer screening due to the high cost [26]. 
Conventional 2D B-scan is mostly used in clinical surveys of many anatomical structures. B-
scan imaging consists of transmitting a short burst of ultrasound energy from transducer 
elements and recording echos received from different depths within the matrix of the tissue 
along the path of the ultrasound beam. The amplitude of a detected echo is represented by the 
brightness of a dot on the display. Multiple sets of dots are combined to depict the echo 
pattern from internal structures within body. The transducer is moved on the surface of the 
body so that structures within are scanned from different directions. The scan line is 
composed of a series of bright dots representing the interfaces encountered along the line of 
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sight. Multiple scan lines are superimposed to create a 2D image that delineates the general 
contour of the tissues, structures and organs. The delineation of the tumour outline is the 
main purpose of the B-mode ultrasound in breast diagnosis.  
Ultrasound is commonly used with x-mammography to analyse whether the abnormality 
detected by the x-ray mammography is a simple cyst (fluid lesion) or a solid tumour (benign 
or malignant lesion), helping prevent unnecessary surgical biopsy. Breast ultrasound is also 
used to detect masses in women with dense breast tissue [10]. This technique is more 
sensistive than mammography for women with dense breast tissue, and it is also used for 
guiding biopsy needles. The ultrasound images enable the radiologist to locate the abnormal 
development in the breast, which is a process known as the ultrasound directed breast biopsy. 
Breast ultrasound shows high sensitivity—94% in invasive ductal carcinoma (IDC) and 86% 
in ductal carcinoma in situ (DCIS) [1].  
Many ultrasound features and appearances of breast lesions based on margin, shape and echo 
texture have been proposed for diagnosis of breast lesions. Malignant lesions are often 
characterised by hypoechoic regions with irregular margins with internal echoes. There are 
other appearances associated with malignant lesions such as microlobulation, 
hypoechogenicity shadowing and duct extension, while benign lesions are characterised by 
clear circumscribed margins that are often round or oval in shape. In addition, in 
mammography and MRI, malignant lesions are often differentiated from the surrounding 
tissue by ill-defined, irregular and non symmetric margins. Benign lesions, on the other hand, 
have well defined and circumscribed margins that are often round in shape [10] (Figure 2.2).  
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Figure 2.2: Image in breast shows breast lesions. (A) Mammogram shows cyst, which is an 
example of a lesion with a circumscribed margin. (B) Mammogram shows invasive cancer, 
which is an irregular margin. (C) Sonogram of a benign cyst. The lesion has round and well-
defined margins with a clear anterior and posterior back wall. (D) Sonogram in 42-year-old 
woman with invasive ductal carcinoma (IDC), which is irregular in shape with irregular 
margins. (E) MRI rim-enhancing image of cyst fluid that is bright on T2-weighted images. 
(F) MRI image of the speculated margin of the invasive ductal carcinoma (IDC) (2004 Berg 
et al. [1]). 
 
2.3. 2D/3D Ultrasound Imaging 
 
The image in conventional ultrasound B-mode imaging is reconstructed using backscattered 
sound energy. This technique, which is referred to as pulse-echo ultrasound imaging, uses a 
simple image reconstruction algorithm that is based on geometrical considerations. It acquires 
multiple beam-formed time traces at different locations, lining them up in image space at one 
angle displaying their amplitudes as greyscale levels and interpreting the time coordinate as a 
measure of axial distance. The image is constructed by displaying the backscattered echo as a 
function of beam direction and sound time of flight (TOF). TOF is the time it takes an 
ultrasound pulse to travel from the source, backscatter from the tissue and undergo detection. 
The B-mode image is a qualitative image that approximately characterises tissue interfaces. 
The conventional 2D imaging is acquired by a freehand probe to build up a 3D dataset of 
irregularly spaced B-scans [27]. The 3D ultrasound and ultrasound computed tomography 
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reconstructs an image from the data collected at various angles. Because the 3D ultrasound or 
ultrasound computed tomography constructs an image from different directions and because 
they are based on small portions of scattered echo, the image typically suffers from distortion 
and poor resolution [3]. 
There are several scanning methods for performing 3D ultrasound imaging [28]. One method 
is freehand imaging, which uses conventional ultrasound technology to create a 3D volume 
from a set of 2D B-scans. This can be achieved by a 3D position sensor that is attached to the 
probe in order to determine the relative positions and orientation for each of the acquired B-
scans. Then, a number of 2D B-scans are built up to construct a 3D volume of interest [28]. 
The 2D B-scans can be visualised individually and assembled into a regular array for 
visualisation and data analysis tasks. These tasks include any-plane reslicing, volume 
rendering, segmentation and quantisation [27].   
Another method is to use a mechanical 3D probe where the third dimension is obtained by 
mechanical movement of the probe in a precise manner. 2D ultrasound images are acquired at 
predefined spatial spaces as the probe is moved. Therefore, the imaging sequence 
reconstructs the volume of interest properly without missing any gaps. In general, this 
method uses the conventional mechanical or linear-array transducer, which is mounted on the 
assembly to allow the translation or rotation of the transducer over the region of interest by a 
motor under computer control [28].  
Most medical ultrasound images are reconstructed with information that is obtained from 
reflected sound energy. It is very difficult to perform ultrasound image reconstruction with 
sound energy that is not directly backscattered into the ultrasound transducer. For instance, in 
the case of ultrasound cardiovascular imaging, signals that are not directly backscattered are 
usually not measurable, due to very large acoustic impedance discontinuities at tissue-bone 
and air-tissue interfaces as well as other attenuation losses [29]. However, breast tissue tends 
to have similar acoustic properties throughout its boundaries, with small differences at tissue 
interfaces, which makes it suitable for more research and development in novel ultrasound 
imaging techniques, especially pulse-echo sound energy [30].  
2.4. Broadband Transducer 
Ultrasound waves are longitudinal displacement waves in an elastic medium, with 
frequencies above 20 kHz. Typically, ultrasound waves are generated by piezocrystals 
excited by an electric potential of corresponding frequency. Ultrasonic technology utilises an 
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array of ultrasonic generators with specific resolution between each of the elements in the 
arrays to achieve specific interference patterns (Figure 2.3), which produce a narrow 
ultrasonic beam that can be focused at up to a 100-mm depth in tissue and in three-
dimensional space, by scanning the individual ultrasound generators (elements) [2]. In this 
system, a single transducer is used for both transmitting and detecting the ultrasound pulses. 
The type of scan (linear), speed of scanning and the spacing (resolution) between acquisitions 
(which depends on the encoder resolution) are usually controlled by a computer with 
specifically designed software. The principle of ultrasonic phased-array technology is very 
similar to that of phased-array radar systems, with the exception of the nature of the waves: 
sound waves instead of electromagnetic waves. The parameters of ultrasound beams 
generated by an ultrasonic phased-array (such as half-width of acoustic pressure, direction, 
focal distance and size of the focal spot) can be controlled by the computerised system. A 
narrow and focused ultrasound beam is achieved by creating the conditions for constructive 
interference between the sound waves generated by each individual element of the ultrasonic 
transducer [31].  
 
Figure 2.3: Beam forming and receiving by a linear-array transducer with same phase and 
amplitude (adapted from Olympus 2007) [2].   
The narrow ultrasonic beam can be scanned linearly across the inspection region, and the 
reflected beam is then detected specific to the tested profile attenuation of the beam and 
visualised on screen after corresponding treatment of the received signal. The reflected echo 
signal carries all the necessary information about the target under inspection: its size, 
morphology and special configuration. Similar to the generation process of ultrasound signal 
by an ultrasonic transducer, the signal received by each of the elements of the array 
transducer is used to reconstruct the image of the target. This idea of the narrow beam of a 
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linear-array broadband transducer can improve spatial resolution and effectively increase the 
depth of the ultrasound field while improving the image quality.  
In order to obtain a narrow and focused beam of ultrasound wave, the specific conditions for 
constructive interference of multiple sound wave-fronts must be fulfilled. The spatial region 
where the wave fronts with maximum amplitude due to constructive interference are 
produced is called the focal point, and the conditions for constructive interference (gain and 
amplitudes of individual waves, digitising frequency, time base etc.) are stored in computer-
controlled software, which fires a sequence of ultrasound waves. This computer program, 
which contains the algorithm for the excitation of individual ultrasound waves, is called a 
focal law. The algorithm contains the resolution between individual firing elements, which 
depend on specific conditions of the testing experiment. Several factors determine the 
specifics of the algorithm, such as focal points, element selection and probe type [2, 31].  
This thesis reported experimental results on ultrasound linear (1D) array transducers whose 
operating frequency range was between 0.5 MHz and 8.5 MHz [2, 31]. Two linear 
transducers were used: one 2.25 MHz with frequencies between 0.5 and 4.5 MHz, and a 
second 5 MHz with frequencies between 2.5 and 8.5 MHz. In the experiment, the transducer 
was scanned mechanically in one dimension (1D) within a water-filled tank, using a 
computer-controlled stepper motor track. This technique was successfully applied to scan full 
3D data of slices in both A-scans and 2D B-scans [31, 32]. The A-scan represents the 
amplitude of the ultrasonic sound as a function of the TOF in microseconds, also known as 
ultrasonic path (UT path) [2, 31, 32]. This provides the possibility to spatially trace the target 
in time [31]. The B-scan presents the recorded ultrasound signal in 2-D visualisation, 
whereby the horizontal axis represents the position of the scan and the vertical axis represents 
the time or ultrasonic path. The axes may be inverted [31]. In this method, the A-scan will be 
used to calculate the broadband ultrasound attenuation of breast lesions and the B-scan will 
be used to segment and quantify the breast lesions.  
 
2.5. Ultrasound Physics and Concepts 
2.5.1. Reflection 
Propagation of sound waves in a tissue is defined by the inertial, restoring and loss 
parameters of the medium. Sound speed is determined by the density and compressibility of 
 16 
 
the medium, and the variations in speed of sound result in refraction of the sound wave. 
Spatial fluctuations in either density or compressibility (which together determine 
characteristic acoustic impedance or sound absorption) may give rise to scattering or 
reflection of the ultrasonic wave. Quantitatively, the velocity of sound is inversely equal to 
the square root of the density of the medium:   
 
                                                             
 
   
                              (2-1)   
where   is the density and K is the compressibility. 
The types of interactions that occur in biological tissues are similar to light reflection, 
refraction, reflection, scattering, diffraction, divergence, interference and absorption. Except 
for interference, all the factors decrease the intensity (loudness of audible sound) of the beam 
(termed the attenuation) of sound energy, due to the tissue. The interference or superposition 
of waves may decrease or increase the intensity and pressure.  The intensity of sound is 
related to the sound pressure as follows: 
 
                                                             
  
  
                              (2-2)   
Where I is the intensity, P is the sound pressure and Z is the acoustic impedance  
In practice, bulk variations of absorption, scattering and attenuation are used to provide 
information about tissue structure. In particular, they all contribute to the complicated process 
of formation, and therefore to the appearance of pulse-echo images. Therefore, knowledge of 
these parameters and their variation with frequency, amplitude, temperature, age, pathology 
etc. is crucial to the ability to understand and make the most efficient use of present and 
potential ultrasonic diagnostic techniques.  
One of the major goals of tissue characterisation is to find suitable methods for extraction and 
careful characterisation of these parameters, based on the measured echographic data. The 
frequency-dependent attenuation of ultrasonic sound is the most important parameter in the 
tissue characterisation process. For example, many pathologies, such as diseased liver, can be 
diagnosed and characterised based on the evaluation of ultrasonic attenuation. Therefore, 
careful characterisation of the attenuation of ultrasonic sound is an important issue in 
ultrasound imaging methodology. Moreover, careful in vitro characterisation of ultrasound 
attenuation is crucial in the diagnosis of breast tumours. The acoustic attenuation of the 
ultrasound signal is a linear function of the frequency of the ultrasound. It is important to 
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have accurate measurements of ultrasonic attenuation in human breast tissue specimens in 
order to differentiate normal from pathological tissue conditions.    
The most important interaction of interest for the ultrasound image is reflection. When an 
ultrasound beam hits an acoustic boundary, part of the beam energy is reflected backward to 
the source, and some is transmitted across the boundary. There are two types of reflection: 
specular and non-specular (usually referred to as scattering) [3]. Specular reflections occur 
when the boundary is smooth and larger in spatial extent than the beam wavelength, while 
non-specular reflections occur when the interface is smaller than the beam.  
 
Figure 2.4: Diagram for spectral reflection which shows the relationship between the angle 
of incidence (i) and the angle of reflection (r) (adapted from Hedrick et al. 2005) [3].   
 
Specular reflectors, such as the diaphragm and pericardium, are interfaces that have diameters 
larger than one wavelength of the applied sound field. High-frequency transducers have 
shorter wavelengths, so they allow the imaging of smaller objects through specular reflection. 
For this type of reflection, the simple law of light (Snell’s Law) governs the reflection of 
light. Because the angle of the incident beam equals the angle of the reflected beam, the 
incident wave will strike the interface perpendicularly, and the reflected beam will return to 
the transducer. The angle between the incident beam and the perpendicular direction to the 
interface is called the angle of incidence. The angle of reflection is the angle between the 
reflected beam and the normal incidence drawn at the line perpendicular to the interface, as 
shown in Figure 2.4. The reflected beam (termed echo) that will travel back to the transducer 
and that will be detected by the machine will increase as the angle of incidence (i) and the 
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angle of reflection (r) decrease. Strong specular reflections will give rise to brighter images 
(hyperechoic and echogenic), because a greater percentage of ultrasound waves will reflect 
back to the transducer to be processed into an ultrasound image. In specular reflection, the 
intensities of the reflected echoes depend on the angle of incidence as well as the difference 
in acoustic impedance between two tissues. Acoustic impedance (Z) is defined as the product 
of the medium density ( ) and sound velocity (c) in the medium:                 
                                                 Z =                                       (2-3)                
For normal incidence, the intensity of the reflected echo as a fraction of the incidence 
intensity is given by the following equation: 
                                            
  
  
 
        
        
                              (2-4)   
where Ir is the reflected echo, Ii is intensity of the incidence beam at the boundary, Z1 is 
acoustic impedance of the first medium and Z2 is acoustic impedance of the second medium. 
The ratio Ir/Ii is called the reflection coefficient, and it indicates the proportion of beam 
intensity that is reflected from the interface. The intensity of echoes increases with increasing 
acoustic impedance difference between the two tissues. If there is no difference between the 
two tissues, no echo will be reflected back. The difference in Z value, called impedance 
mismatch or discontinuity, causes some portion of the ultrasound to be reflected at the 
interface; this amount of impedance mismatch allows the visualisation of soft tissue 
structures with an ultrasound beam [3].  
 
Another important interaction between the ultrasound beam and tissue is known as non-
specular reflection, or scattering. Non-specular reflection does not obey the simple law of 
reflection, but depends on the number of the scatters per volume, size of the scatters, acoustic 
impedance and the diameter of the ultrasound beam. Therefore, detection of an echo by the 
same beam-producing transducer requires that the energy be incident upon the small target 
and at quite a large angle of incidence. Scattering happens when the reflecting interface is 
smaller than the physical dimensions of the size of the wavelength of the beam. The 
wavelengths of clinical diagnostic beams are 1 mm or less, so scattering beams provide much 
useful information about the internal texture of organs that have dimensions of less than 1 
mm. Scattering beams are much weaker than specularly reflected beams. However, the high 
sensitivity of modern ultrasound devices make it possible to use information from scattered 
beams for imaging. The scattering beam shows strong frequency dependence, increasing 
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rapidly as the frequency of ultrasound increases, while specular reflection shows no 
frequency dependence. 
 
2.5.2. Spatial Resolution  
Image quality is of the most importance in determining the image’s usefulness. The overall 
quality of the ultrasound image is the end product of a combination of many factors, such as 
spatial resolution, the transducer and image processing, which affect the final quality of the 
ultrasound image. Spatial resolution is described as the measure of how closely objects in an 
image can be distinguished from each other. It affects the ability of the imaging scanner to 
depict tissue details. It is also known as the ability of the ultrasound device to distinguish 
between two objects that are very close together in a sample. Ultrasound frequency can affect 
spatial resolution. Spatial resolution is also divided into axial and lateral resolution. 
Axial resolution is the ability to distinguish between two separate objects that lie one above 
the other along the axis of an ultrasound beam (Figure 2.5). It is determined by the spatial 
pulse length and the wavelength and frequency of the ultrasound wave, which have a major 
impact on image quality. The spatial pulse length (SPL) is the spatial extent of an ultrasound 
pulse burst. The spatial pulse length is the product of the number of cycles in the pulse and 
the wavelength. Axial resolution is inversely proportional to the frequency of the ultrasound 
wave. As the frequency of the transducer is increased, the axial resolution consequently 
increases [3, 29]. In addition, axial resolution is affected by the spatial pulse length (SPL), as 
reflectors closer than half the spatial pulse length cannot be distinguished. The spatial pulse 
length of an ultrasound beam is approximately 1–3 wavelengths of the beam. The shorter the 
spatial pulse length, the better the axial resolution [3]. Because frequency and wavelength are 
inversely related, the spatial pulse length decreases with increasing beam frequency and it 
subsequently results in better axial resolution. As a higher frequency beam experiences more 
attenuation than a lower frequency beam at longer distances along the axis of the ultrasound 
beam, the frequency composition of the detected echo will shift to a lower frequency, with a 
loss of resolution.   
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Figure 2.5: The relationship between pulse length and axial resolution. (A) Both objects 
(dots) are covered by a five-cycle pulse. (B) The objects can be distinguished by a two-cycle 
pulse which has a shorter spatial pulse length (adapted from Hedrick et al. 2005) [3]. 
By way of contrast, lateral resolution is defined as the ability to distinguish between 
structures lying side by side. Lateral resolution is dependent on the width of the beam (beam-
width) , the depth of the tissue and beam frequency. Ultrasound beam can be determined by 
transducer frequency, since beam divergence within far field increases with lower 
frequencies. Reflectors that closer to one another than the width of the beam cannot be 
distinguished (Figure 2.6.A). While, two objects can be distinguished by a narrow beam if 
they are separately by less than less of beam width. Lateral resolution is highly dependent 
upon the depth of imaging. Therefore, lateral resolution is better in shallow organs and worse 
with deeper imaging. Lateral resolution is usually proportional to the frequency of the 
ultrasound transducer, meaning that higher frequency results in better lateral resolution [29]. 
Thus, as frequency increases, resolution improves accordingly. However, since, due to 
attenuation, signal amplitude decreases, it is possible to use high frequencies until SNR 
becomes an impediment and frequency cannot be increased any more.  
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Figure 2.6: The relationship between lateral resolution and beam width. (A) Both objects 
cannot be distinguished with a wide beam. (B) Two objects can be distinguished by a narrow 
beam when the beam is scanned across the objects (adapted from Hedrick et al. 2005) [3]. 
 
Because higher beam frequencies are associated with better spatial resolution but suffer more 
attenuation, which affects adequate penetration and the resolution of the depth of interest, it is 
necessary to use lower frequency beams to achieve increased depth of penetration in tissue. 
Broadband transducers are designed to provide a wide range of frequencies in the same 
ultrasound beam. In a typical ultrasonic transducer, the broadband transducer with a centre 
frequency of 5 MHz has a frequency response of 3 MHz–7 MHz. This transducer has a 
shortened pulse length, for better axial resolution. Therefore, broadband transducers have the 
combined benefits of the high spatial resolution of the higher frequency components and the 
deeper tissue penetration of the lower frequency components.  
 
2.5. Quantitative Ultrasound Measurement 
For quantitative measurements, four parameters prove to be of great importance. These 
include the attenuation of acoustic energy [33-37], the speed of sound [38-45], frequency 
dependent scatter properties[46-50] and the regularity (similar acoustic properties) of the 
structure through tissue [51, 52]. In clinical situations, all the above processes can occur at 
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the same time. Thus, when quantifying a given parameter, it becomes a necessity to consider 
any possible interactions that may arise from the other processes [18]. 
 
The main concern of this thesis is the characterisation of broadband ultrasound attenuation in 
tissue. A simple method for measuring or quantifying the frequency dependent attenuation 
has been demonstrated in this project. In this method, the transducer could be driven by a 
broadband pulse at fixed centre frequency that has a number of frequency components for the 
determination of  ultrasound amplitude reduction.  The slope of the linear regression between 
attenuation (dB) and frequency (MHz) is referred to as BUA.  
 
Acoustic energy attenuation, which occurs during propagation, is a complex process or 
phenomenon. Two mechanisms primarily have the responsibility for attenuation of energy 
[46, 48, 49]. These include scatter of the energy out of the acoustic pathway and absorption in 
which acoustic energy undergoes transformation to thermal energy. These two mechanisms 
interact frequently, especially in biological tissues, leading to acoustic attenuation, which has 
an approximately linear frequency dependence on the frequency range of typical ultrasound 
equipment. Attenuation is mainly given in decibels of signal power dissipated per centimeter 
of propagation per megahertz. Two measurement schemes have been used to measure the 
attenuation of acoustic energy in vivo [18]. These include the loss of signal amplitude [43-45] 
and the shift in the frequency spectrum of the rf signals which are received at various depths 
[39-42]. 
One of the vital things to highlight is the loss of energy in biological tissues, associated with 
the scatter mechanism. The factor between these two is small compared to absorption [49]. 
Yet, when observing a backscattered signal in the reflectance mode, the observed signal 
energy is dependent on the scatter mechanism. Variation of the backscattered signal 
amplitude occurs due to the changing crosssection of the tissue [18]. The scatter mechanism 
is a very minor contributor to the overall attenuation [46] to the extent that even a significant 
change in the level of scatter will exert a minor effect on the total attenuation. In addition, 
when you consider a case where the crosssection changes in frequency dependent scatter, this 
will not affect the total signal attenuation in a significant way. However, this would cause the 
backscattered signal to have a spectral shift in a frequency domain [18]. Such a shift would 
lead to vagueness and ambiguity when interpreting the level of tissue attenuation [39].  
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The technique of ultrasonic power spectra was first reported and used in Serbia around 1967 
[53, 54]. The use of the spectral shift method to characterise the attenuation of acoustic 
energy in tissue was first used by Kuc [39, 40]. When applying the spectral shift method, one 
measures the spectral shape of various segments belonging to the rf echo along the A-mode 
vector. The frequency dependence of attenuation can possibly be determined by the distance 
between the distal and proximal spectra [18]. From research, it is possible to obtain a 
Gaussian shaped attenuation spectrum which has a peak frequency linearly shifted 
downwards in frequency domain [38, 39].  
Ultrasound attenuation is an important acoustic parameter of soft tissue. It is essential in two 
clinical events for the characterisation of soft regions. The initial event entails the 
examination of localised lesions, for example, discrete localised masses situated within a 
homogeneous ordinary organ. The subsequent event entails evaluation of the entire 
attenuation within large masses, or oversize tissue regions with diffuse disease or whole 
organs [55]. In certain cases, the pathological condition of tissue can alter the acoustic 
properties due to losses via reflection, dispersion and absorption. Attenuation of localised 
lesions has been characterised in B-mode imagery by the occurrence of acoustic shadowing 
or enhancement of the posterior echoes (i.e. the amplitude of the returning echoes from the 
far side of a lesion). Attenuation in large masses or regions with dispersed disease or whole 
organs are generally estimated by the relative penetration of the ultrasound beam. Usually, B-
mode imaging uniformly shows the echoes in the near and far fields by using time-gain 
compensation (TGC) to even out variations in the intensity of near and far echoes [55]. 
Previous research has established the utility of acoustic characteristics such as attenuation, 
speed of sound and backscatter in characterising breast tissue [55-58]. From the time that 
Greenleaf et al. [59] assessed that acoustic dimensions such as speed and shadowing made 
with transmitted ultrasound could be employed to characterise breast tissue, different 
investigators have come up with transmission ultrasound machinery, such as scanners, in an 
effort to determine transmission parameters and to imitate their results in vivo [60-62]. A 
number of quantitative outcomes for attenuation measurement via ultrasound tomography 
demonstrate that, for internal fatty tissues in the breast, the calculated attenuation value is 
about 0.91 dB/MHz/cm, whereas breast cysts show a value of 0.06 dB/MHz/cm for 1 MHz 
[63], which is relatively lower than the former.  
Although ultrasound tomography is a valuable method to measure these acoustic factors, 
comparatively few research studies and experiments have been carried out to determine 
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attenuation by means of pulse-echo systems. Rotstein and Neerhut [64] examined the 
attenuation factors of persistent ductal carcinoma (IDC) by means of shadowing and 
enhancement to the lesion, and established that it was more likely for high-grade IDC to 
originate posterior enhancement or posterior isoechogenicity (59%), compared to classic or 
standard posterior shadowing (30%). Quantitative examination of attenuation coefficients for 
different breast–adipose tissue (AD) together with carcinomas (CA) illustrates that the 
comparative attenuation coefficient to nearby tissues of fibroadenomas (FA) is 0.270 
dB/MHz/cm, of CA is 0.21 dB/MHz-cm and of AD is 0.02 dB/MHz/cm [65]. 
 
2.6. Attenuation Estimation Methods 
Linear frequency dependence by attenuation in soft tissues is an assumption utilised by 
diverse attenuation estimation methods reported in literature [18, 66]. These methods take 
two approaches, namely, frequency domain and time domain [17]. These approaches form a 
dualistic relationship where the signal of one domain is described by characterising the signal 
in the other domain. Generally, the techniques involving time domain compution are faster 
and easier to implement than those of frequency domain. However, several frequency-domain 
methods have been studied and developed due to their advantages over other techniques, 
which have complexities in compensating for local variations in the acoustic field in the 
direction of beam propagation, that is, diffraction effects [17]. In addition, the estimation 
performances of dissimilar methods can be affected by several factors, for instance, the 
power law of scattering, frequency-dependent attenuation, specular reflection, beam profile 
and bandwidth of the incident pulse [17, 18]. The section below sums up classical attenuation 
estimation methods, that is, the time-domain approach and the frequency-domain approach 
[17]. 
 
2.7. Classical Approaches for the Estimation of Attenuation Values 
Traditionally, changes in the signal amplitude as the incident acoustic wave propagates 
through tissue were used to approximate attenuation values in the time domain. This method 
was shown to be the primary quantitative feasibility of attenuation estimation [44, 45]. 
Measurements taken to determine the disparity in the amplitudes of the backscattered echoes 
from two areas of interest in tissue, assuming a Gaussian shaped incident pulse [38]. Based 
on the dualistic relationship between frequency and time domains, Rice [67] demonstrated 
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the relationship between the probable densities of zero crossing found in stochastic waveform 
and the square root of the second moment of the power spectrum of that waveform. If the 
fractional bandwidth is small, the estimation of the attenuation coefficient can be generated 
by measuring the zero crossing density of the backscattered ultrasound signal [18]. The 
estimation of frequency-domain spectral downshift is facilitated by the measurement of zero 
crossing density of the signal. To demonstrate the relationship between the attenuation 
parameter and the zero crossing density (𝜆) of the signal, the following formula is used: 
                        𝜆    
            
          
           
          
         (2-5) 
where    and  
  are the center frequency and variance of the transmit pulse, respectively, Zo 
is total pulse propagation distance and    is a material parameter. Tissue attenuation power 
factor n is usually assumed to be equal to or greater than 1 [68]. In this method, time-domain 
representation is obtained by converting frequency dependent attenuation property. However, 
the length of segment of ultrasound data used to extract short-term variations in the frequency 
domain can influence the estimation accuracy. 
Greenleaf and He [69, 70] approximated the attenuation coefficients in the time domain by 
using the local maximum of the echo signal envelope. Jang et al. [71] came up with a method 
that would measure disparity between two neighboring segments of narrowband echo signal. 
By assuming the attenuation in the area under examination to be uniform, this method 
approximated attenuation by lessening the disparity in the entropy of the segments as 
attenuation was constantly compensated. This technique attained sensible approximation 
results utilising comparatively short lengths of the ultrasound data segment. Lately, B-mode 
video techniques have also been developed to measure approximate attenuation from the B-
mode images [72]. The VSA (video signal analysis) technique calculates the ratio of mean 
echo amplitude from a model to that from a reference phantom scanned using matching 
transducer settings. The relative echogenecity against depth produces information on the 
attenuation of the model. While this technique attained precise approximation performance in 
universally attenuating areas at shallow depths of scanned tissue, it was unsuccessful in 
approximating attenuation values at deeper depth when broadband incident pulses were used. 
As illustrated earlier, time-domain methods are faster and easier to implement than are 
frequency-domain methods. However, findings from earlier research have disclosed that 
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frequency-dependent attenuation is related to the spectral components of ultrasound data. In 
addition, it is hard to compensate for diffraction effects as the beam propagates in the time 
domain. Since soft tissue ultrasound attenuation is normally presented in terms of energy loss 
from the ultrasound beam because of scattering and absorption, power in backscattered 
ultrasound signals directly shows the energy lost as the beam propagates in the frequency 
domain. Therefore, many frequency-domain methods have been investigated to study 
acoustic attenuation.  
There are two primary methods utilised to approximate the attenuation coefficient in the 
frequency domain: spectral difference and spectral shift. The first method utilises the 
amplitude of power spectra or its intensity decay resulting from the backscattered RF signals. 
The ratio (or disparity) of power spectra between two different depths is related to the 
attenuation characteristics of the scanned tissue [17]. 
The spectral shift method is the other approach for approximating attenuation from a 
backscattered ultrasound signal. Soft tissue exhibits low-pass filter properties because, 
naturally, the ultrasound signal monotonically increases with frequency. This soft tissue 
frequency-dependent attenuation characteristic lowers the power spectra to lower frequencies 
along the beam propagation course. This swing in power spectra acquired between areas at 
two dissimilar depths or data segments is also associated with the attenuation properties of 
the scanned tissue. Kuc [66] summed up these two approaches of frequency–domain in a 
seminal paper, which is revisited in brief in the next subsections. 
Ophir et al. [73] used the amplitude decay throughout the propagation course of the beam, 
utilising narrowband pulses, to study the circumstances under which precise approximates in 
vitro and in vivo attenuation could be acquired. While this technique provided a good 
approximation of the attenuation coefficients over a number of bands of frequencies in 
similar tissue materials, for example, spleen and liver, it was fruitless in approximating the 
attenuation coefficient precisely in different materials where the common scattering 
characteristics change.  
Kuc [66] approximated attenuation utilising the slope of the disparity between the logarithms 
of echo signal spectra acquired from tissue of dissimilar depths. Kuc also studied the lower 
limit of the attenuation approximations variances for spectra difference and spectra shift 
methods utilising a maximum likelihood approximation. In Kuc’s computations, the lower 
bound on the variance of attenuation approximate was negatively correlated to the product of 
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the usable bandwidth in backscattered signals (W) and the axial block size that was used to 
compute the power spectrum (D). From the computations, Kuc [66] found that the lower 
bound for a single backscattered signal was proportional to (WD) 
-3
, while that for the whole 
scanning area was (WD) 
-4
. 
Wilson et al. [74] built on the use of a linear regression method through the use of a 
smoothed log power spectra. The author built a computationally efficient method by 
interchanging operators. The author developed this method with the precise results reviewed 
in terms of tissue homogeneity and frequency linearity. Identical algorithms have been 
established to measure attenuation both at precise frequencies and in focal lesions. 
Additionally, the authors also assessed in vivo measurements for pathological and normal 
livers. 
Yao et al. [75] developed a reference phantom technique to lessen system and transducer 
reliance as well as diffraction effects. The backscatter and attenuation parameters of the 
reference phantom were known. This reference phantom method attained precise frequency 
dependent attenuation approximation performance, in agreement with other spectral 
difference techniques. 
Fink et al. [76] developed a centroid downshift technique utilising a short time Fourier 
transform to approximate the spectral shift. Dynamic tissue characteristics were well 
accounted for utilising this short time Fourier study method, and the spectral centroid value’s 
time reliance allowed for the approximation of frequency-reliant attenuation. This 
approximation technique is one of the primary techniques for approximating spectral shift 
inherent in the frequency domain. 
2.8. Presently Used Signal Processing Techniques  
The most common method is Fourier transform of ultrasound signals (used to derive the 
spectra of amplitude) and phase to approximate attenuation and dispersion of a medium, 
respectively. The main aim of these frequency techniques is to reduce ambiguity in the phase 
unwrap computation. Zhao et al.’s [4] method is based upon the time frequency study 
method, known STFT, to approximate the ultrasonic attenuation. In this method, only 
amplitude information of pulse signal spectra is utilised. 
The attenuation coefficient is obtained by calculating the amplitude decay of the pulse 
spectrum in the time domain based on the time-frequency presentation [4]. This technique 
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relies on time-frequency presentation to approximate the ultrasound attenuation by computing 
the pulse spectrum’s amplitude decay in the time domain. The proposed new method of BUA 
approximation that is to be used in this thesis is based on the short-time Fourier transform 
method (using MATLAB spectrogram applied on signals). This is in order to approximate the 
ultrasound attenuation coefficient (dB) by comparing the amplitude of spectra of the 
ultrasound signal with the maximum amplitude (reference) of spectra at particular 
frequencies (MHz). In this technique, all the transducer frequencies will be utilised to 
determine the broadband ultrasound attenuation. The slope of the linear regression (e.g. 
between 0.5 and 2.5 MHz) is called BUA, which has a unit of dB/MHz.  
 
 2.9. Broadband Ultrasound Attenuation 
The interaction of an ultrasonic beam with an inhomogeneous medium has the effect of 
progressively decreasing the intensity of the ultrasound beam as it travels through the 
medium. This process is termed attenuation. Attenuation should be distinguished from 
absorption, as approximately 80% of energy that is lost is converted into heat by the process 
of absorption [77],  and attenuation refers to the total propagation losses that result in a 
reduction of beam intensity. These losses include those due to specular reflection, frequency 
response of the ultrasonic scatters, refraction and absorption. In other words, absorption is 
one of the factors that contribute to attenuation. Attenuation is an exponential function that 
depends upon the distance travelled, exact composition of the medium and the frequency of 
the ultrasound beam. The higher the frequency of the ultrasound beam, the greater the 
attenuation; thus, at higher frequencies, transducers have less tissue penetration due to greater 
attenuation, which make it difficult to image deeper organs. For example, a 5 MHz transducer 
shows very high-resolution images, but it cannot penetrate deeply into the body. On the other 
hand, a lower frequency transducer shows poor overall resolution of the image and penetrates 
deeply, due to less attenuation per unit of distance (cm)[3].    
Attenuation represents a combined effect of absorption and scattering. In the frequency range 
1-7 MHz, which is the clinical frequency range for breast, the total attenuation is linearly 
proportional to frequency: 
                                          μ (f) = α f                  (2-6) 
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where α is the slope of attenuation against frequency (dB MHz-1 cm-1). The amplitude 
spectrum of Ab (f) of a pulse through tissue can be expressed as a function of the reference 
pulse Aw (f) through water: 
                      Ab (f) = Aw (f) . е 
– μ (f) x 
 Ttb Tbt          (2-7) 
where Ttb is the transmission coefficient from soft tissue to tissue and Tbt is the transmission 
coefficient from tissue to soft tissue, assuming the transmission coefficient between water 
and soft tissue to be unity. 
Solving for the attenuation (dB cm
-1
) produces the following: 
 
                      μ (f) = 
     
 
 ln (
     
      
  + ln (Ttb Tbt)  (2-8) 
Linear regression of the spectral amplitude difference provides the slope of attenuation (dB 
MHz
-1
 cm
-1
). In clinical practice, over the frequency range 0.2–0.6 MHz, this has become 
known as BUA [78] (Figure 2.5). 
 
Regarding the relative measurements, the intensity at a point is compared to that at some 
defined reference point, and is expressed in decibels (dB). The intensity change or level 
expressed in decibels is as follows:  
                                                  
 
    
           (2-9) 
  
where I is the intensity at the point of interest and       is the reference intensity. There is a 
relationship between the amplitude and the intensity, which may be utilised to calculate 
intensity change. The square of the amplitude is proportional to the intensity, as follows: 
                                                 
  
    
 
 
  
 
    
            (2-10) 
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where       is the intial peak amplitude of the beam and     is the peak amplitude at the 
point of interest. Substituting Equation (2-9) for      
  , the relation in Equation (2-9) is used 
as follows:  
                                                 
  
    
   (2-11) 
 
Attenuation coefficient is the attenuation that occurs with each centimetre the ultrasound 
wave travels; it is measured in decibel/centimetre (dB/cm). The farther the ultrasound waves 
travel, the greater the attenuation. Attenuation is usually determined by two factors: length of 
path and frequency of the ultrasound wave. Distance and frequency are directly related to 
attenuation [29]. Ultrasound attenuation, therefore, can be determined by the following 
equation for a given sample thickness and ultrasound frequency:             
                             Attenuation =         
  
  
      (2-12)                      
where    represents the amplitude of the wave through the sample and    represents 
amplitude through water. The units of ultrasound attenuation are decibels (dB).  
BUA can be calculated by comparing amplitude of spectrum of the ultrasound signal with 
and without the sample in position (Figure 2.7), using the FFT analysis, providing a plot of 
attenuation against frequency. The slope of the linear regression (e.g. between 0.2 and 0.6 
MHz) is called BUA, which has a unit of dB/MHz (Figure 2.8) [79]. 
 
Figure 2.7: Graphical representation showing the amplitude spectra of a sample and  
reference material (maximum amplitude).  
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Figure 2.8: Graph showing the relationship between attenuation and frequency (1–7 MHz) as 
a linear function. These frequencies were chosen based on the transducer being used and 
tissue.  
Figure 2.8 shows the dependence of the attenuation signal as a function of the frequency for 
the system under investigation. The attenuation was calculated by using Eq. (2-12). As one 
can see, the relation between the attenuation and the frequency is approximately linear 
function at particlar frequencies for a particular tissue.  For example, the attenuation for the 
Acrylic is found to increase approximately linearly with the frequency from 1 to 3 MHz for a 
2.25 MHz transducer. The BUA is clinically used to assess osteoporosis by investigating the 
relationship between BUA within the bone and bone mineral density, since the calcaneal 
BUA provides information on both bone structure and density [80].  
 
This thesis focuses on developing and scientifically validating the quantitative 3D broadband 
ultrasound technique using a flat-bed pulse-echo scanner. I will develop a novel software to 
detect and identify breast lesions based on short-time Fourier transform, and this software 
will also be validated using ultrasound needle breast biopsy phantom from CIRS. This 
software, which is based on variable-frequency ultrasound, will be used to create a novel 3D 
BUA (dB/MHz) image of breast lesions.  
Chapter 3 provides an introduction to the flat-bed scanner and its components, such as 
Olympus Omniscan. It also introduces the instruments, materials and phantoms that will be 
utilised in order to fulfill the research objectives. The methods for validation of spatial 
resolution, 3D spatial accuracy of the flat-bed scanner and 3D BUA assessment of breast 
lesions will be presented. The Method section will provide a description of the imaging 
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processing and digital signal processing procedures used for determining the novel 3D 
broadband ultrasound attenuation (dB/MHz) assessment of breast lesions.   
Chapter 4 presents the results of spatial resolution using general purpose multi-tissue 
ultrasound phantom and home-built wire phantom, 3D spatial accuracy of flat-bed scanner 
using breast phantom and 3D BUA characterisation of breast lesions.   
Chapter 5 discusses the implications of the results and the estimation accuracy and reliability 
of the flat-bed scanner. 
Finally, Chapter 6 presents a summary of the results and discusses the limitations of the BUA 
technique and further directions.  
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Chapter 3: 
Research Methodology 
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3. Research Methodology 
The scanning imaging system utilised in this research consists of an ultrasound test 
instrument (Omniscan), Tomoview software, motion control (Stepper motor), phased-array 
broadband transducer and scanner (flat-bed scanner) (Figure 3.1). The Omniscan phased 
array ultrasound unit is used with 128 transducer elements in a phased-array that can perform 
electronic and sector scans. Omniscan can operate fully automated scanners and encoders and 
record all waveform data. It can perform pulse-echo and display slices of A-scan, B-scan and 
S-scan. Two phased-array transducers are used that have centre frequencies of 2.25 and 5 
MHz, containing 128 elements with a pitch of 0.75 mm. The phased-array scan is performed 
with one single phased-array transducer that has a source beam width of approximately 100 
mm, facing the side of the phantom.  
 
Figure 3.1: The experimental set-ups for Phased Array system 
 
Tomoview software is used on the computer for both data aquisition and hardware control for 
all inspections using the linear phased-array transducer. Tomoview provides the software 
components necessary to control the excitation of the amplitude and time delay (focal law) of 
the individual elements in the transducer. The excitation of the transducer elements can 
generate beams with constructive interference. The flat-bed scanner allows transducer 
movement with resolution of 1 mm between slices. The transducer is combined with 
mechanical stepping in order to acquire 3D data of slices of 2D B-scan of the inspected 
volume, with electronic scanning in one direction using the Tomoview (Figure 3.2-3). 
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The scanning imaging system allows export of the 3D data of the phantom for further 
analysis. The 3D data is exported to external softwares such as Simpleware and MATLAB. 
Simpleware offers three software options, ScanIP, ScanFE and ScanCAD, for converting 2D 
images into a 3D model. Simpleware can perform several tasks, including the pre-processing 
of regions of interest for image enhancement and optimisation, segmentation for locating 
regions of interest and creating 3D models. The software applies intelligent tools that use 
mathematically sophisticated algorithms to recognise complex patterns in images.  
MATLAB provides signal processing tools to examine specific data. The 3D data of slices of 
A-scan will be processed. The MATLAB spectrogram uses STFT, which is a spectral 
representation of signals, that is, the amplitudes of different spectra in the amplitude-time 
profile at a particular frequency (MHz). The 3D Spectrogram program can create a 3D map 
(time in micro second (depth of the phantom) x slices (transducer positions) x transducer 
elements x colour coded for amplitude) of the phantom at particlar frequencies. The 
amplitudes of the pulse signal spectra are calculated and compared with maximum amplitude 
in each A-scan at certain frquencies (e.g. 1:5 MHz) in order to determine the ultrasound 
reduction (dB). There would be five attenuation programs, and the sixth program would be 
for regression analysis to determine the broadband ultrasound attenuation (dB/MHz). Since 
the slope of the linear regression between attenuation and frequency is referred to as BUA, it 
has a unit of the dB/MHz. The final product is 3D BUA (dB/MHz) of breast lesions. 
3.1. Equipment and Tools  
 The proposed flat-bed ultrasound scanner with flexible mesh. 
 Olympus Omniscan MX ultrasound system. 
 Two 128-element broadband transducers of 2.25 MHz and 5 MHz from Olympus 
(these frequencies are in agreement with attenuation measurements for the breast 
phantom developed by (CIRS)). 
 Voulson scanner uses linear 11 MHz transducer. Since a conventional 2.5-5 MHz 
clinical scanner was not available.    
  MATLAB. 
 Ultrasound needle biopsy breast phantom is composed of tissue-mimicking materials 
with a solid elastic materials comprising a vacuum degassed, liquid based acrylamide 
polymerized resin matrix. Since the liquid comprises ethylene glycol and resin matrix 
comprises homogenously suspended particles and a suspending agent. Where the 
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solid elastic material has a speed of sound within the range of of 1420 m/s to 1650 
m/s and a sonic attenuation within the range of 0.1 to 1.5 dB/MHz/cm in the 
frequency range of 2 to 10 MHz found in an average human breast [81]. This phantom 
is developed by CIRS tissue simulation technology.  
 General purpose multi-tissue ultrasound phantom that is used developed by CIRS. 
 Built-home wire phantom that has a rectangular shape with two perspex bases with a 
thickness of 5 mm each, and the specifications of the rectangular wire is 85 mm 
(length) by 45 mm (width) by 1:10 mm (height). The height starts at 10 mm and 
decreases 1 mm at a time.  
 Faro arm device.  
 Acrylic sample with calibrated attenuation coefficient of 1.28 dB/MHz/cm. The 
attenuation was measured by Selfridge [82]. Since it was 6.4 dB/cm at 5 MHz, so the 
BUA at 1 MHz would be 1.28 dB/MHz/cm. 
 Simpleware program for imaging analysis.  
 Sliceomatic Graphic User Interface (GUI) from MATLAB. 
 
Figure 3.2: Flat-bed ultrasound scanner  
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Figure 3.3: Flat-bed Scanner, showing phased-array transducer and motor driven scanner  
3.2. Omniscan Device Settings  
These instruments are controlled by many software programs, such as Olympus’ Tomoview 
software. In order to obtain constructive interference in the desired region of the sample, each 
individual element of the virtual probe aperture has to be computer-controlled for a firing 
sequence, using a focal law. 
3.2.1. Focal Law Calculator 
The focal law calculator is a vital phased-array tool that calculates the specific delays for all 
active elements in customised calculation, which includes scan and probe type, specimen and 
element selection. Based on these calculated values, the system will enable the firing 
sequence. For the flat-bed ultrasound scanner, the parameters are configured as follows: 
 Scan type: linear  
 Probe frequency (MHz): 2.5 MHz/5 MHz 
 Specimen: water 
 Element selection: pulser start 1, stop at 124 and resolution at 4. Primary axis aperture 
is at 4 (Start) 
 Wedge: contact. Sound velocity (m/s) at 1540 m/s 
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 Figure 3.4: Configuration for the advanced calculator, where we can select the frequency 
(2.25 MHz), transducer element, sample, speed of sound (1540 m/s) etc. 
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3.2.2. Ultrasound Settings 
The UT settings contain several important basic tabs, as shown in Figure 3.5: general, gate, 
time correction gain (TCG), digitiser, pulse/receiver, probe, alarm, I/O, and Transmitter and 
Receiver to perform the experimental works. 
The parameters of ultrasound settings for the flat-bed ultrasoud scanner are configured as 
follows: 
 Gain tab: channel is 25 dB, focal law is 10 dB and time base (starting from 0 mm to 
about 40 mm, depending on the inspection depth). 
 Digitiser tab: digitising frequency is 100 MHz or 50 MHz, depending on the time base 
(inspection depth), i.e. as the inspection distance increases, the digitising frequency 
should be decreased. Recurrence (Pulse repetition frequency) is 2000. Average is at 
either 1 or 4 (Figure 3.6). 
 
Figure 3.5: Configuration for the ultrasound settings (general), where we can adjust the gain 
to get a clear image, and the range of inspection in mm 
 
 
Figure 3.6: Configuration for the digitiser, where we can adjust the digitising frequency and 
number of the sample 
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3.2.3. Software Control of Stepping Motor  
Tomoview provides the software components necessary to control the motorised inspection 
sequences. Tomoview offers the sequence types predefined with typical values. In order to 
integrate with the stepper-motor control and save data for the inspection area, there are 
conditions which have to be met, such as the resolution for the probe element (focal law 
calculator) and resolution for sequence. For example, if the resolution for element probe is 1, 
then the resolution for inspection sequence should be 1 (Figure 3.7). Also, the distance that 
the motor will move should be a real number, such as 71 mm (as shown in Figure 3.8). 
 
 
 
Figure 3.7: Configuration for the inspection sequence, where we can select the Type of scan 
(i.e. one line scan), Step (200) and Resolution (1 mm) 
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Figure 3.8: Configuration for motor drive, where we can select the distance of movement (71 
mm) and the speed of motor (1mm/s) 
 
3.2.4. Procedures for Exporting A-scan and B-scan Using Tomoview  
After all settings are configured as shown above, the scan is linearly performed in one 
dimension within the water tank in order to collect 3D data of slices of A-scan and B-scan of 
a phantom. If we wish to export the data as A-scan, we should choose Channel Numbers, and 
if we wish to export the data as B-scan, we should choose Merge All (Figure 3.9).  
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Figure 3.9: Export datagroup, where we can select to export A-scan or B-scan 
   
3.3. Scientific Validation Studies 
The experiments were performed by mechanically scanning the transducer in 1D within a 
water-filled tank, using a computer-controlled stepper motor track with a resolution of 1 mm, 
which allowed collection of full 3D data of slices of 2D B-scan and A-scan of the 
investigated phantom. Significant components of the technique’s development are the image 
processing software Simpleware and signal processing of the ultrasound data using 
MATLAB. The second significant component of the ultrasound scanner is the scanning tank. 
The water bath provides a means of reliable ultrasound coupling and a flexible mesh that 
supports the phantom. This approach eliminated the requirements for conventional gel 
coupling.  
The flat-bed scanner used novel, multi-frequency 3D pulse-echo technology to generate a 
variety of signals at the surface of the phantom. The signals that derive from phantom 
interactions reveal information about the phantom, including external texture and contents of 
the phantom. In most applications, data were collected over the surface of the phantom and 
two- and three-dimensional images were generated displaying spatial variations in the 
phantom. The pulse-echo ultrasound system being proposed was a system that allowed a 
whole volume of data to be acquired from a single scan at one angle. It also enabled both a 
brightness scan (B-scan) and a 2D amplitude scan (A-scan), which can be used in quantitative 
ultrasound assessment at the same time. When the three-dimensional volume of data was 
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acquired, the volume could be analysed in several different ways. For example, the volume 
could be processed to create volume-rendered displays, or the data could be re-sliced to 
reveal 2D images in planes. 3D ultrasound data could be reconstructed by using a phased-
array ultrasound transducer to construct a volume of intensity data from the pulse-echo 
information. The 2D image of the phantom under investigation was displayed using the flat-
bed scanner and MATLAB program, after which a 3D model of the phantom was made using 
a computer program known as Simpleware. The MATLAB spectrogram was also capable of 
performing quantitative analysis that determined BUA (dB/MHz) on the phantom. 
This project considered the application of quantitative 3D ultrasound (Q3D) for the 
assessment of breast lesions. It involved a balance of the experimental development of the 
flat-bed scanner utilising novel, multi-frequency 3D pulse-echo technology, along with 
scientific validation. I have developed and scientifically validated novel software based on 
short-time Fourier transform that can be used by a user to classify breast lesions. This 
software has been used to create 3D BUA images of breast lesions.  
3.3.1. Validation Method for Spatial Resolution  
General purpose multi-tissue ultrasound phantom was used to investigate the spatial 
resolution of the flat-bed ultrasound scanner using 2.25 and 5 MHz linear-array transducers. 
The phantom is designed to allow for assessment of uniformity, axial and lateral resolution, 
depth calibration and dead zone measurement, with two different attenuations of 0.5 and 0.7 
dB/MHz/cm. Two experimental measurements were performed with 2.25 and 5 MHz linear-
array transducers to obtain 2D B-scans that could be displayed using MATLAB.  
Home-built wire phantom 84 mm long x 45 mm wide x 1–10 mm high was also carefully 
scanned using the flat-bed ultrasound scanner with 2.25 and 5 MHz broadband transducers 
and the GE Voluson scanner with an 11 MHz linear transducer in order to investigate the 
reliability of the flat-bed scanner in terms of spatial resolution. 3D data of slices of 2D 
images was obtained from the two systems. The flat-bed scanner uses a broadband transducer 
that provides the advantages of high frequency for high spatial resolution and low frequency 
for much deeper penetration, while the GE Voluson operates at either high frequency or low 
frequency. The 2.25 MHz linear-array transducer has a range of frequencies between 0.5 and 
4.5 MHz, while the 5 MHz linear-array transducer has a range of frequencies between 1 and 
7.5 MHz. The Faro arm, which is capable of computing the position of its end probe in 3D 
space to an accuracy of 0.005 mm, was utilised to collect 3D data of 2D images of the entire 
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phantom, as the GE Voluson scanner only allows us to acquire consistent 3D data of a 
thickness of 9.5 cm. The wire phantom, which was home-built, had dimensions of 85 mm 
long x 45 mm wide x 10 mm height. Then, this 3D data was exported to external software 
such as MATLAB and Simpleware. 2D images of the phantom were obtained and stacked 
together with the aid of Simpleware. Therefore, a 3D ultrasound model of the phantom could 
be produced in an STL format to determine the dimensions of the wire phantom.  
3.3.2. Validation Method for 3D Spatial Accuracy Using Breast Phantom 
Experiments were carried out using a flat-bed ultrasound scanner and an ultrasound needle 
breast biopsy phantom with amorphous/irregular lesions to detect, and perform volume 
measurements on the lesions in order to investigate the 3D spatial accuracy of the flat-bed 
scanner. Within the phantom, there were six solid masses and six cystic masses, which were 
positioned randomly. The phantom consisted of material based on a solid elastic water-based 
polymer. The same measurements were performed on the breast phantom using the GE 
Voluson scanner, and the results were compared with the results for the flat-bed scanner in 
order to investigate the reliability of flat-bed scanner.  
3.3.2.1. Image Analysis  
The phantoms were carefully scanned using the flat-bed ultrasound scanner and the GE 
Voluson scanner, and two-dimensional images were obtained from both systems. 3D data of 
slices of the 2D B-scan of the phantom were obtained from the systems, and the 2D images 
were imported into Simpleware (ScanIP and ScanCAD) [83]. The ultrasound images 
produced from the scan were then stacked together with the aid of the Simpleware computer 
program, so that one 3D ultrasound image was produced in an STL format. This program 
worked by performing histogram image processing, image segmentation and 3D 
reconstruction. The 3D reconstruction was formed based on overlaying quantitative 
ultrasound parameters such as specular reflection and acoustic impedance, and it allowed us 
to study the volume measurements and spatial resolution.  
The Faro arm device has six degrees (joints) of freedom and an articulated arm (Figure 3.10). 
A probe was attached to the end. The articulated arm was passive, which implies that it could 
be manually moved and held in the desired position. The control Box contained highly 
sophisticated signal and numerical transducers that allowed for the reading of raw data and 
the conversion of this raw data into dimension coordinates. A program provided by Faro was 
run on the same PC to convert the digitised reading of the joint transducers into a set of six 
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numbers representing the position (x,y,z) and the orientation of the probe holder with respect 
to a coordinate system attached to the base of the arm. 2D ultrasound images for a whole 
phantom were collected using the GE Voluson scanner along with information on the 
position and orientation of each image. Reference points were traced on the relevant images 
and the points transformed from image space to real world space.  
 
Figure 3.10: Experimental set-ups for FaroArm system to study the 3D spatial resolution 
 
The steps of the image processing analysis were as follows: 
 The 2D images of the phantom obtained by the GE Voluson scanner were cropped to 
reduce the physical extent of the image volume in x, y, z directions and were stored 
for comparison with images that were obtained from the flat-bed scanner. 
 The resolution of the 3D data were 1 mm (x), 0.308 mm (y), 1 mm (z) for 2D images 
obtained by the flat-bed ultrasound scanner, while the resolution of Voluson data were 
0.169 mm (x), 0.169 mm (y), 0.5 mm (z), which would determine the size of the data 
by the number of the pixels they contained. The resolutions of the 2D images obtained 
by the GE Voluson scanner were determined by Image J software. 
  Histogram equalisation was performed on the images, and the window of the 
greyscale values was changed in order to choose the value in which the region of 
interest lies, to obtain optimal/clear images.  
  Each object within the volume was represented by a mask, which was the 
segmentation of the background data. These masks could be worked on, modified and 
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filtered within ScanIP until the results were adequate to convert into a model. The use 
of mask restricts the operation (filtering) on certain pixels/some parts of the image.   
 Several masks could be performed within ScanIP by filtering the original data, and 
filters could be applied to masks individually. A ScanIP project was saved as sip 
(format) for further imaging processing. 
 A segmentation tool within ScanIP was utilised to use information from the 
background image data (pixel information) to modify or create a mask. A 
segmentation tool could be manual, such as Paint (most efficient way for segment 
data), or assisted, such as threshold and FloodFill. Segmentation can be performed 
with threshold within 255 (greyscale), and threshold slider within ScanIP allowed the 
updating of the active slide view in order to find the right values (from 1–255) to 
segment the dataset. FloodFill is an algorithm that finds connected regions of interest 
based on similarity information in order to fill with a particular colour. This algorithm 
is utilised in colouring the solid and cystic breast lesions. Some of the segmentation 
tools were interactive, such as threshold and FloodFill, and could be applied in 2D.  
 After importing the data, many image processing techniques such as segmentation and 
smoothing were performed on the data. First, the segmention of regions of interest 
was performed on slices, using a confidence connected region growing algorithm. 
This algorithm is a very efficient tool that starts by choosing an initial set of small 
areas that are iteratively merged according to similarity constraints. Then, a FloodFill 
algorithm was performed on slices in order to find the optimum lower and upper 
threshold parameters to use. These algorithms needed to be performed on masks. In 
addition, regions of interest were segmented using the Paint tool, which is very useful 
tool in segmentation, despite being time-consuming. The Paint point-to-point line 
mode was used to allow us to paint the boundaries quickly, and the FloodFill 
algorithm was used to fill the inside in that slice. A smoothing recursive Gaussian 
filter was utilised in order to reduce noise in the image. The next step was to generate 
and export a 3D model in STL format.  
  Most segmentation tools can create a new mask, merge the results of the 
segmentation of the current active mask or replace with the active mask.  
 A recursive Gaussian filter, which is an algorithm for smoothing the data of the region 
of interest, was used to remove image noise and to smooth the contours of the object 
based on pixel size.  
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 The ScanIP model could be saved in the sip format, as mentioned, for further image 
processing. 
 In order to generate a surface model, the surface export functionality allowed surface 
meshes to be exported as STL. In addition, the model could be smoothed within the 
STL preview settings by performing a pre-smoothing.  
 All distance (in mm) measurements were done using the measurement tool in ScanIP.    
 ScanCAD allowed the import of segmented data to create a CAD model that could be 
manipulated interactively using the rotate and translate button. In addition, ScanCAD 
allowed an STL model to be imported into the ScanCAD to perform rotation and 
translation manually to combine models into one model and study the spatial 
accuracy.  
3.3.3. Validation Method for Novel Quantitative 3D Ultrasound Attenuation Assessment  
I developed and scientifically validated novel software that can be used by a user to classify 
lesions based on upon the quantitative image analysis provided, i.e. BUA map. The breast 
phantom, which had an attenuation coefficient of 0.1–1.5 dB/MHz/cm and velocity of sound 
through the medium of 1540 m/s, was mechanically scanned to collect 3D data of slices of A-
scan. These slices of A-scan were processed to determine a 3D BUA (dB/MHz) measurement 
of the breast phantom. The three dimensions of BUA are slice number or transducer 
positions, transducer elements and time (depth of the phantom) and the four dimensions 
indicated in the colour-coded BUA (Figure 3.12 at the lower corner). The red colour had a 
higher BUA value, and the light blue colour had a lower BUA value. The depth of the 
phantom was validated by calculating the thickness (time (0.000118 s/2) x velocity of sound 
(1540 m/s) is equal to 9 cm). The calculated normalised BUA depending on the volumetric 
parameter (i.e. BUA divided by thickness of the phantom that is 9 cm) values of 0.29–0.76 
dB/MHz/cm were within the range of the attenuation coefficients (0.1–1.5 dB/MHz/cm) of 
the CIRS breast phantom.  
This method was based on STFT, which is a time–frequency analysis (Figure 3.11) to 
determine the ultrasound attenuation (dB), and subsequently, the BUA (dB/MHz) [4, 76]. 
Typically, the signals are processed using MATLAB. To approximate the ultrasound 
attenuation coefficient (dB), the amplitudes of different spectra in the amplitude-time profile 
at a particular frequency (MHz) are compared with that of the spectrum having the highest 
amplitude in each profile. Five attenuation coefficients were obtained at five frequencies. The 
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slope of the linear regression, referred to as BUA, has a unit of the dB/MHz. This is divided 
by the sample depth, depending on the volumetric parameter, to give normalised BUA in 
units of dB/MHz/cm.  
A MATLAB spectrogram using STFT can be generally described as a spectral representation 
of a wave (in this case, a sound wave) in which time is used as a variable at a particular 
frequency. A spectrogram can be used to form an image, as shown in Figure 3.11. 
3.3.3.1. Data and Image Analysis Using Spectrogram 
 RF data was digitised and stored from a set of slices of A-scans of the phantom. This set of 
slices of A-scans could consist of independent separate slices that comprised a volume. 3D 
data of the breast phantom in the format of A-scan were obtained using the 128 element 
linear-array transducer. The txt file was loaded and represents it in the correct 3D format. The 
number of transducer positions (160) and the number of points (time samples) per time 
domain vector (3180) were determined. Windows then were applied to the RF signals; these 
typically were sliding windows that selected RF data for analysis in a series of small steps 
e.g. steps of 256 samples for a window. The spectrogram was based on the time-frequency 
method, and uses STFT to determine the ultrasonic attenuation. The amplitudes of the signal 
spectra were calculated using short time intervals at a certain frequency. This method was 
based on the determination of the ultrasound attenuation by computing the pulse spectrum 
amplitude that decayed with time. The spectrogram command computer program would be 
fed 3D data of a phantom extracted from the echo-pulse ultrasound scanner and allowed to 
produce 3D from 2D spectrograms. All the 2D spectrograms were built up to create a 3D 
spectrogram. The X axis represented the slice number or transducer position and the Y axis 
represented transducer element number (1:4:124). The Z axis indicated the four dimension of 
coloured coded amplitude (time domain (s)) at a particular frequency (MHz). For example, 
red indicated a higher value of amplitude around a particular frequency in time domain and 
blue indicated a lower value of amplitude. The amplitude axis can be either linear or 
logarithmic scale.  
A reference (maximum) amplitude component could then be chosen and incorporated into the 
3D program in order to create 3D ultrasound attenuation analysis at a particular frequency. 
This could be accomplished by observing carefully and recording maximum amplitude from 
spectra in time domain in each amplitude-time profile. Then, the ultrasonic attenuation (dB) 
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was calculated as 20.log1010 [Sample Amplitude (V) / Reference (maximum) Amplitude (V)] 
[79].  
 
 
Figure 3.11: (a) Amplitude-time analysis of sample called A-scan; (b) Profile of amplitude 
against time for a frequency of 2.25 MHz in each signal of (a), echoes originated from front 
and back faces of Plexiglas plate (adapted from Zhao et al. 2005) [4].   
Figure 3.11 shows examples of time-resolved ultrasound echo-pulses sent through the 
phantom and received from the scanned phantom. The two amplitudes of signals were 
separated in time by approximately 4 microseconds, which gave an estimate of the distance 
and time the ultrasound travels though the phantom. The amplitudes of signal were measured 
at an ultrasound frequency of 2.25 MHz.  
In order to carry out the determination of 3D BUA, first, 3D ultrasound attenuation at 
different frequencies (e.g. 0.5, 1.0, 1.5, 2.0, 2.5 MHz) of ultrasound signals through the 
phantom were computed by determining the amount of decrease in amplitude of the 
ultrasound signal from spectra in time domain as it travelled through the phantom. Second, 
these amplitudes of spectra were compared with maximum amplitude of spectra in each 
amplitude-time profile. Then, the attenuation coefficient values at different frequencies were 
obtained and aligned to give a BUA index of units measured in dB/MHz, using regression 
analysis between attenuation coefficient values and certain frequencies (Figure 2.8). Then, 
3D BUA (dB/MHz) was displayed based on overlaying of novel quantitative ultrasound 
parameters of BUA slope using Sliceomatic volume slice visualisation GUI (Graphical User 
Interface) from the MATLAB website [84]. Figure 3.12 shows the flowchart for producing 
novel 3D BUA (dB/MHz) software that could be used by the user to classify breast lesions.  
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Figure 3.12: Flowchart for the Novel BUA (dB/MHz) Method Processes 
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Chapter 4:                                         
Results 
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4.1. Introduction  
Chapter three identified the methodologies that were selected to empirically investigate the 
research propositions. This chapter reports on the outcomes of spatial resolution, 3D spatial 
accuracy and 3D quantitative ultrasound assessment of breast lesions.  
4.2. Spatial Resolution of Flat-bed Ultrasound Scanner  
The general purpose multi-tissue ultrasound phantom is designed to allow for assessment of 
uniformity, axial and lateral resolution, with different background attenuations of 0.5 and 0.7 
dB/MHz/cm (Figure 4.1) to investigate the spatial resolution of the flat-bed scanner using 
2.25 and 5 MHz transducers. The system allows 2D data of B-scans that could be used to 
display 2D images. The 2D B-scans in txt format were used to display using MATLAB. The 
results of the 2.25 MHz transducer with background 0.5 dB/MHz/cm shows some near field 
circles, axial and lateral resolution, deep circles and cystics (See Figures 4.1, 4.2 A). While 
the result of the 2.25 MHz transducer with background 0.7 dB/MHz/cm showed clearer 
image of near field circles and a less clear image of axial, lateral resolution and depth circles 
and cystics compared with the 0.5 dB/cm-MHz background (Figures 4.1, 4.2 B). On the other 
hand, the results of the 5 MHz transducer with background 0.5 dB/cm-MHz showed a clearer 
image of near field circles and better axial and lateral resolution, but a less clear image of 
cystics compared with the results of the 2.25 transducer (Figure 4.2 C). The results of the 5 
MHz transducer with background 0.7 dB/cm-MHz transducer showed near field circles, axial 
and lateral resolution and depth circles but a less clear image than the results of the 5 MHz 
transducer with background of 0.5 dB/cm-MHz, particularly for cystics (Figure 4.2 E). As 
you can see, the 5 MHz transducer showed better spatial resolution with stronger echo for 
several features of the phantom, such as near field circle, axial and lateral resolution, deep 
circles and cystics, compared with the 2.25 MHz transducer (Figure 4.2 A,B,C,E and F). It 
was also noted that the 2.25 MHz transducer showed deeper penetration ultrasound that 
showed more information of deep near field objects and deep cystic objects (Figure 4.2 A and 
B).  
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Figure 4.1: Side view of the general purpose multi-tissue ultrasound phantom, which shows 
near field, axial resolution, lateral resolution and deep circles and cystics. 
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Figure 4.2: Side view of the general purpose multi-tissue ultrasound phantom, which shows 
near field, axial resolution, lateral resolution and deep circles and cystics. A, B, C and E are 
the experimental results for both transducers with different backgrounds of 0.5/0.7 dB/cm-
MHz, while F is a graph of the side view of the phantom. 
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Other experiments were performed on a home-built wire phantom, which had dimensions of 
85 mm length x 45 mm width x 10 mm height, using 2.25 and 5 MHz broadband transducers 
with length 96 mm. These experiments were carried out in order to investigate the spatial 
resolution of the flat-bed scanner. The 3D ultrasound data obtained from the system had 
spatial resolutions of 1 mm length (lateral resolution) x 1 mm width x 0.308 mm height (axial 
resolution). Then, this 3D data was exported to external softwares such as MATLAB and 
Simpleware. 2D images of the phantom were displayed in the Portable Network Graphic 
(PNG) format using MATLAB and stacked together with the aid of Simpleware. Therefore, 
the 3D ultrasound model of the phantom could be produced in an STL format to determine 
the dimensions of the wire phantom. The results showed that there were similar results 
between the true dimensions and measured dimensions, as shown in Figures 4.3 and 4.4. 
Since the true and measured dimensions for the 2.25 MHz transducer were 85 mm length x 
45 mm width x 10 mm height against 84.72 +/- 0.09 mm x 45.4 +/- 0.19 mm x 10.06 +/- 0.12 
mm, respectively. In addition, the true and measured dimensions for the 5 MHz transducer 
were 85 mm length x 45 mm width x 10 mm height against 84.85 +/- 0.11 mm x 44.99 +/- 
0.12 mm x 9.99 +/- 0.14 mm, respectively. The measurements were repeated five times to 
determine the standard deviation. In addition, the results showed good spatial resolution of 
the flat-bed ultrasound scanner based on pulse-echo technology.    
               
                  
Figure 4.3: 3D image of a home-built wire phantom which has dimensions of 85 mm x 45 
mm x 10 mm using a 2.25 MHz ultrasound transducer.  
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Figure 4.4: 3D image of a home-built wire phantom which has dimensions of 85 mm x 45 
mm x 10 mm using a 5 MHz ultrasound transducer. 
 
4.2.1. Comparative Study of Spatial Resolution Using Wire Phantom  
The measurements were performed on the wire phantom using the Voluson scanner to study 
the relaibility of the flat-bed scanner. The images that were most consistent were collected 
using the Faro arm. The Faro arm was moved 9.5 mm in the z dimension to record another set 
of 19 slices, each of which had a thickness of 0.5 mm; totally, the thickness was 9.5 mm. 
Then, the distance would be increased 9.5 mm each time to record another 19 slices until we 
covered the width of the wire phantom. The x and y dimension values needed to be constant 
to obtain consistent images. After the first group (about 190 slices) was recorded, the Faro 
arm was returned to the first position and moved 41 mm in the y dimension to record the 
second group of 2D Voluson images of the phantom to cover the wire phantom. The width of 
the 11 MHz transducer was smaller than the width of the phantom. The resolutions of these 
2D images were 0.169 mm (axial resolution) x 0.169 mm, and the thickness of this image 
was 0.5 mm (lateral resolution). These 2D images of the first group were stacked together to 
create a 3D image and converted in STL using ScanIP to determine the dimensions, as shown 
in Figure 4.5. As can be seen in Figure 4.5, the measured dimension of the phantom was 
42.93 mm using 11 MHz linear transducer. Figure 4.6 shows the dimensions of 45.07 mm.  
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The two groups of the segmented models were imported into ScanCAD and converted into 
CAD. The two numerical models were translated to match with each other utilising the 
coordinate values of the Faro arm. Figures 4.7 and 4.8 show the complete model from two 
different views in CAD format. The true and measured dimensions for the 11 MHz 
transducer were 85 mm (length) x 45 mm (width) x 10 mm (height) against 84.60 +/- 0.43 
mm x 44.90 +/- 0.15 mm x 9.91 +/- 0.19 mm, respectively. The measurements were repeated 
five times to determine the standard deviation. In addition, similar experimental results were 
obtained from the flat-bed scanner and the GE Voluson scanner. The results for the Voluson 
scanner were 84.60 +/- 0.43 mm (length) x 44.90 +/- 0.15 mm (width) x 9.91 +/- 0.19 mm 
(height), while the results (5 MHz) for the flat-bed scanner were 84.85 +/- 0.11 mm (length) x 
44.99 +/- 0.12 mm (width)x 9.99 +/- 0.14 mm (height) with the 5 MHz transducer (see Table 
4.1).  
   
Figure 4.5: 3D image of first model using Voluson scanner, which has dimensions of 43 mm 
x 45 mm x 10 mm using an 11 MHz linear ultrasound transducer. 
 58 
 
       
Figure 4.6: 3D image of second model using Voluson scanner, which has dimensions of 43 
mm x 45 mm x 10 mm using an 11 MHz linear ultrasound transducer. 
 
     
Figure 4.7: 3D image of wire phantom using GE Voluson after performing translation and 
combining the two models into one model using ScanCAD.   
 
 59 
 
 
Figure 4.8: Different view with one colour for 3D image of the wire phantom using the GE 
Voluson scanner. The wires look thicker on the left side because the image basically 
consisted of two separate images. They were imported into ScanCAD and combined together 
to give a single image. The left-side image is slightly different in the orientation due to 
rotation and translation processes (please section 3.3.2.1 under methodology) and right-side 
has normal orientation.     
Table 4.1: A very good agreement between the true and measured wire dimensions for three 
transduers.  
Transducer (MHz) True Dimension (mm) Measured Dimension (mm) 
2.25 
Length 85 84.72 +/- 0.09 
Width 45 44.8 +/- 0.19 
Height 10 10.06 +/- 0.12 
5 
Length 85 84.85 +/- 0.11 
Width 45 44.99 +/- 0.12 
Height 10 9.99 +/- 0.14 
11 
Length 85 84.60 +/- 0.43 
Width 45 44.90 +/- 0.15 
Height 10 9.91 +/- 44.99 
 
4.3. 3D Spatial Accuracy of the System 
The 3D spatial accuracy of the flat-bed scanner includes two features. The first was the 
relationship between different dimensions or volumes, and the second is the relationship 
between total 3D ultrasound volume and the phantom/sample being scanned. This is achieved 
by marking a sign in some images that were obtained using the GE Voluson scanner with the 
Faro arm. This sign in yellow colour can be segmented using Simpleware and utilised as a 
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reference point to transform image space to real world space in order to study the relationship 
between the total 3D ultrasound volume and the phantom being scanned.  
4.3.1. 3D Spatial Accuracy of Flat-bed Ultrasound Scanner Using Breast Phantom 
The measurements were performed on an upside down breast phantom with six solid and 
cystic masses that were positioned randomly. Two 2.25 and 5 MHz broadband linear-array 
transducers with length 96 mm were utilised to investigate the 3D spatial accuracy of the flat-
bed scanner. The breast phantom was scanned by the transducer in approximately three 
minutes to obtain 3D data of the entire phantom. The 3D data of the phantom were formed 
based on overlaying quantitative ultrasound (QUS) parameters such as specular reflection and 
acoustic impedance. The 3D ultrasound data obtained from the system had spatial resolutions 
of 1 mm length x 1 mm width x 0.308 mm height. Then, this 3D data was exported to 
external softwares such as MATLAB. In Figure 4.9-10, the solid lesions in the red circle are 
characterised by hypoechoic and internal echo, while the fluid lesions (yellow circle) are 
characterised by bright and small area. There are some features at the sides around the 
phantom and from the top of the water surface due to reflection that need to be neglected (see 
Figure 9.9-10).  2D images of the phantom were displayed in the Portable Network Graphic 
(PNG) format using MATLAB and converted into STL using ScanIP. Six cystic and solid 
masses were measured. Therefore, the 3D numerical model of the phantom could be 
produced in an STL format to determine the volumes, locations and shapes of the masses 
within the phantom.  
Figure 4.11 shows segmented data of the solid and cystic masses using the 2.25 MHz 
transducer, with a table that shows the measured volumes of the masses plus the standard 
deviation obtained from the volume analysis in the ScanIP. The purple solid mass had a 
volume of (1.64 x 10
3
 +/- 12.6) mm
3
, the brown solid mass had a volume of (946 +/- 19.7) 
mm
3
, the blue solid mass had a volume of (1.65 x 10
3
 +/- 20.6) mm
3
, the green solid mass 
had a volume of (2.40 x 10
3
 +/- 21.7) mm
3
, the bright green solid mass had a volume of (655 
+/- 12.1) mm
3
 and the red solid mass had a volume of (1.63 x 10
3
 +/- 11.4) mm
3
. Also, Figure 
4.12 shows the 3D model of the solid and cystic masses using the 5 MHz transducer, with a 
table that shows the measured volumes of the masses plus the standard deviation obtained 
from the volume analysis in the ScanIP. The purple solid mass had a volume of (1.64 x 10
3
 
+/- 12.6) mm
3
, the brown solid mass had a volume of (942 +/- 49) mm
3
, the blue solid mass 
had a volume of (1.65 x 10
3
 +/- 35.5) mm
3
, the green solid mass had a volume of (2.41 x 10
3
 
+/- 39.4) mm
3
, the bright green solid mass had a volume of (659 +/- 17.1) mm
3
 and the red 
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solid mass had a volume of (1.67 x 10
3
 +/- 18.1) mm
3
. Figures 4.10 and 4.12 show cystic 
masses that were very small compared to the solid masses, due to low attenuation, but these 
were not possible to segment measurably.  
 
  
Figure 4.9: A longitudinal scan of breast phantom showing two solid lesions inside the red 
circles using a 2.25 MHz phased-array transducer. The depth distance should be 
approximately 98.9 mm , since pixel number (319) x depth resolution (0.31) which is equal to 
98.9 mm.  
 
Figure 4.10: A longitudinal scan of breast phantom showing one solid lesion inside the red 
circle and one fluid lesion inside the yellow circle using a 5 MHz phased-array transducer. 
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Figure 4.11: Segmented data of solid and cystic masses (in pink colour) using a 2.25 MHz 
transducer, with a table for volume analysis  
             
 
              
Figure 4.12: Segmented data of solid and cystic masses (in pink colour) using a 5 MHz 
transducer, with a table for volume analysis.   
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4.2.2. Comparative Study of 3D Spatial Accuracy Using Breast Phantom 
The experiments were performed on a breast phantom using the GE Voluson scanner in order 
to study the relaibility of the flat-bed scanner in terms of 3D spatial accuracy. The 3D 
ultrasound data obtained from the system using the 11 MHz linear transducer had spatial 
resolutions of 0.169 mm length x 0.169 mm width x 0.5 mm height that were measured using 
Image J. In Figure 4.13, the solid lesions in the red circle are characterised by a bright and 
large area with internal echo, while the fluid lesion (yellow circle) is characterised by a samll 
area with high attenuation and large area with low attenuation. The resolutions of these 2D 
images were 0.169 mm x 0.169 mm, and the thickness of this image was 0.5 mm. Then, this 
3D data of 2D images was exported to Simpleware. The 2D images of the first group were 
stacked together to create 3D image and were converted in STL using ScanIP to determine 
the volumes and locations of cystic and solid masses, as done in Figure 4.14.  
Figure 4.14 shows the first group and the second group of the breast lesions with a table that 
shows the measured volumes of the masses plus the standard deviation obtained from the 
volume analysis within ScanIP. The purple solid mass had a volume of (1.64 x 10
3
 +/- 18.6) 
mm
3
, the brown solid mass had a volume of (942 +/- 33.1) mm
3
, the blue solid mass had a 
volume of (1.62 x 10
3
 +/- 40) mm
3
, the green solid mass had a volume of (2.42 x 10
3
 +/- 
17.6) mm
3
, the bright green solid mass had a volume of (651 +/- 29.5) mm
3
 and the red solid 
mass had a volume of (1.64 x 10
3
 +/- 24.4) mm
3
. The yellow object in Figure 4.14 was 
positioned in some of the slices as a reference point to tranform the image space to real world 
space. The pink colour indicated the cystic masses. The two groups of the segmented data 
were imported into ScanCAD and converted into CAD. The two numerical models were 
translated to fit with each other utilising the coordinate values of the Faro arm. Figure 4.15 
shows the complete model from top view in CAD format. Figure 4.16 shows the image for 
the comparative study between the two 3D models taken from the GE Voluson and flat-bed 
ultrasound scanners.    
Figure 4.16 shows the image for the comparative study between the two models. The left 
image was obtained using the GE Voluson scanner and the right image of the breast lesions 
was obtained using the flat-bed ultrasound scanner. The measurements were performed using 
11 MHz linear and 2.25 MHz phased-array transducers. Figure 4.17 shows an image for the 
comparative study between the two models. The left image was obtained using the GE 
Voluson scanner and the right image of the breast lesions was obtained using the flat-bed 
ultrasound scanner. The measurements were performed using 11 MHz linear and 5 MHz 
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phased-array transducers. Figures 4.15 and 4.17 show the image from the top view, while 
Figures 4.16 and 4.17 show the image from the back view. Figures 4.16 and 4.17 show the 
relationship between the total 3D ultrasound volume and the phantom being scanned. This 3D 
image shows the six solid lesions. It can be seen that the 3D image of the breast lesions was 
inverted after performing image processing on the image using Simpleware, as the right and 
left sides of the image were interchanged.   
 
 
 
Figure 4.13: A longitudinal scan of breast phantom showing (a) one solid lesion inside the 
red circle and (b) fluid lesion, using an 11 MHz linear transducer. 
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Figure 4.14: 3D image of the first group (left) and the second group (middle) of the breast 
lesions with a table (right) for volume analysis using the GE Voluson scanner with an 11 
MHz linear transducer showing six solid lesions, pink objects indicated to cystic masses and 
a reference point that is in yellow colour.  
 
 
Figure 4.15: Segmented data of solid and cystic masses using an 11 MHz linear transducer. 
The yellow mass was used as a reference point for the total 3D ultrasound volume.  
 66 
 
    
Figure 4.16: Image for the comparative study between the two models: the left image was 
obtained using the GE Voluson scanner and the right image of the breast lesions was obtained 
using the flat-bed ultrasound scanner. The measurements were performed using 11 MHz 
linear and 2.25 MHz phased-array transducers.  
 
Figure 4.17: Image for the comparative study between the two models: the left image is a 
back view obtained using the GE Voluson scanner and the right image is a back view of the 
breast lesions obtained using the flat-bed ultrasound scanner. The measurements were 
performed using 11 MHz linear and 2.25 MHz phased-array transducers.  
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Figure 4.18: Image for the comparative study between the two models: the left image was 
obtained using the GE Voluson scanner and the right image of the breast lesions was obtained 
using the flat-bed ultrasound scanner. The measurements were performed using 11 MHz 
linear and 5 MHz transducers  
 
 
Figure 4.19: Image for the comparative study between the two models: the left image is a 
back view obtained using the GE Voluson scanner and the right image is a back view for the 
breast lesions obtained using the flat-bed ultrasound scanner. The measurements were 
performed using 11 MHz linear and 5 MHz phased-array transducers.  
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4.4. Quantitative Ultrasound (e.g. BUA) Assessment 
This is early work for validation of the BUA method using an acrylic perspex phantom with 
thickness of 49.9 mm that explains the idea of the BUA analysis using fast Fourier transform 
(FFT). Two ultrasound techniques were used to validate the BUA method.  
4.4.1. Pulse-echo Technique  
In this technique, an ultrasound transducer emits a frequency ultrasonic pulse towards the 
sample, where it is reflected back to the same transducer. The FFT and BUA can be measured 
in the acrylic perspex phantom, which has a given value of BUA in dB/cm/MHz (1.28 
dB/MHz/cm taken from the website of the NDT) as follows: calculate the spectrum of both 
front surface and back surface signals in the sample. This spectrum is amplitude against 
frequency (centred at 2.25 MHz) (see Figure 4.20). Then, calculate the attenuation as a 
function of the frequency via Equation (2-11). Finally, perform regression analysis of the 
selected frequency range, for instance from 0.5–2.25 MHz. In Figure 4.20, the spectrum 
analysis for front and back signals was performed by FFT analysis, which indicated the 
relationship between the amplitude against the frequency. It can be seen in Figure 4.20 that 
the spectrum was centred at 2.25 MHz for the 2.25 MHz phased-array transducer for specific 
transducer element (number 50).  BUA was derived as the slope of a linear fit of the 
attenuation as a function of frequency in the selected frequency bandwidth (1 - 3 MHz) for 
2.25 MHz transducer (see Figure 4.21). 
4.4.2 Transmission Technique 
Two ultrasonic transducers are used: one acting as receiver and the other as a transmitter of 
the ultrasound wave. Experimental activities included measuring water, removing the bubbles 
from the samples, and measuring thicknesses of the acrylic phantom in mm using a Vernier 
caliper, ensuring accurate positioning of the sample between the two ultrasound transducer—
i.e. to the central axis of the ultrasound beam and parallel. These measurements are obtained 
using 1 MHz and 3.5 MHz paired transducers. BUA can be determined by comparing the 
frequency spectrum of a signal with the sample in position and without the sample in 
position. This is done by using FFT analysis and providing a plot of attenuation against 
frequency. The gradient of the linear regression is referred to as BUA, which has a unit of 
dB/MHz. In Figure 4.22, spectral analysis for a thickness of 49 mm for front and back signals 
was performed by FFT analysis, indicating a relationship between the amplitude and the 
frequency. Note that in Figure 4.22 the spectrum was centred at 3.5 MHz for the 3.5 MHz 
signal transducer. Figure 4.23 shows the regression analysis between the attenuation (dB) 
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versus the frequency (MHz). Finally, the slope of the regression was calculated in dB/MHz, 
which is called BUA (dB/MHz).  
 
 
Figure 4.20: Frequency spectrum for acrylic phantom with thickness (W) of 49.9 mm for 
pulse-echo transducer (2.25 MHz) for transducer element number of 50.   
 
Figure 4.21: BUA analysis for acrylic phantom with thickness (W) of 49.9 mm for pulse-
echo transducer (2.25 MHz) element number of  50. The BUA value for the 2.25 MHz test = 
6.4 dB/MHz.  
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Figure 4.22: : Frequency spectrum for acrylic phantom with thickness (W) of 49.9 mm for 
single transducer (3.5 MHz)  
 
 
Figure 4.23: BUA analysis for Acrylic phantom with thickness (W) of 49.9mm for single 
transducer (3.5MHz).The BUA value for the 3.5 MHz test = 6.4 dB MHz^-1  
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Table 4.2: Matching of the normalised BUA values between the experimental and published 
value  
Ultrasound 
Technique 
Frequency 
(MHz) 
Acrylic 
Thickness 
(cm) 
Experimental 
BUA in 
dB/MHz 
Experimental 
nBUA in 
dB/MHz/cm 
published 
nBUA in 
dB/MHz/cm 
Mean nBUA 
(dB/MHz/cm) 
 
Sample 
S.D.  
Pulse-Echo 2.25 and 5 49.9 6.43 1.29 1.28 
1.25-/+0.05 -/+ 
0.05 
Transmission 3.5 49.9 6.407 1.29 1.28 
1.31-/+0.04 -/+ 
0.04 
 
This early work for validation of quantitative ultrasound (BUA) assessment was achieved 
using two ultrasound techniques: transmission and echo-pulse ultrasound technique. The 
acrylic clear phantom has an attenuation value of 6.4 dB/cm at 5 MHz, which could be 
written as 1.28 dB/MHz/cm [82]. The transmission ultrasound measurement has been done 
with two signal transducers, 1 MHz and 3.5 MHz. Also, the echo-pulse ultrasound 
measurement has been performed with a 2.25 MHz pulse-echo transducer. Standard deviation 
was calculated for five measurements, which showed how much the variation from the 
average value of nBUA, and the value of the standard deviations were less than 0.04% of the 
mean nBUA for pulse-echo technique, which indicated that the data points were very close to 
the mean nBUA. In addition, there was a good match between the mean experimental BUA 
value, which was (1.25 -/+ 0.05) dB/MHz/cm at 2.25 MHz, and the published BUA, which 
was 1.28 dB/MHz/cm at 5 MHz (see Table 4.2 and corresponding graphs). Therefore, our 
BUA technique could successfully determine BUA within an acrylic phantom.  
4.5. Early Work for BUA Analysis on Bone Phantoms  
The BUA analysis was performed on two commercial bone BUA phantoms from CIRS. One 
issue arose in relation to the BUA measurements. First, we looked into two commercial BUA 
phantoms for bone (one with BUA value of about 76 dB/MHz/cm and the other with BUA 
value of about 50 dB/MHz/cm) acquired from Canada. The signals were fully attenuated 
within the phantoms. Because the frequency range for our transducer is 0.5–2.25 MHz, while 
the frequency range for BUA evaluation for the phantoms is 0.25–0.5 MHz, which is 
indicated in the documents that come with the phantoms. So to solve this problem in future, 
we need adjust the pulse-echo ultrasound transducer to a lower frequency close to the clinical 
frequency range (for bone), which is 0.2–0.6 MHz.    
 72 
 
Also, It was found when we looked into the breast phantom using a 10 MHz phased array 
transducer that signals were fully attenuated within the phantoms. Because the frequency 
range for our transducer is approximately 5–15 MHz, while the frequency range for the 
phantoms is 2–10 MHz.  
4.6. Frequency-Time (attenuation (dB)) Analysis on a Cylindrical Sample Using STFT  
This early study aimed to investigate the ultrasound spectra at different frequencies. One of 
the methods to perform sliding window STFT is the MATLAB spectrogram. A spectrogram 
is a time varying spectral representation which can form an image. A MATLAB spectrogram 
command was utilised to perform a 2D spectrogram across all 3D data of a cylindrical disc 
phantom (with circle holes at edges), which was extracted from the flat-bed ultrasound 
scanner. Each spectrogram was a 2D function of frequency and time. Then, all 2D 
spectrograms were used to create a 3D image at different frquencies. All spectra were 
calculated at the same position and orientation with different frequency (1-5 MHz) (Figure 
4.24). The Z axis represented time (s), the Y axis represented transducer postions (1:151) 
and the X axis represented transducer elements (1:4:124). The fourth dimension indicating 
the amplitude of a particular frequency (MHz) at a particular time (s) was represented by 
colour of each point in the image. For example, the red indicates a larger value of amplitude 
around a particular frequency at a particular time (see Figure 4.24), and the blue indicates a 
smaller value. The amplitude axis could be either linear or logarithmic scale (in decibel (dB)) 
in our case. The red colour was a bigger value of amplitude around 3 MHz (see Figure 4.24 
middle right-hand image) at a particular time (s) and at a particular slice, and the blue was a 
smaller value of amplitude around 3 MHz at a particular time (s) and at a particular slice. 
The spectra at 1:4 MHz are strong but at 3 and 4 MHz are stronger, as be seen in the red 
cycles. However the spectrum at 5 MHz was very poor because this spectrum is outside of 
the frequency distribution of 2.25 MHz, since the frequency distributions of 2.25 MHz are 
0.5:4.5 MHz. This technique produced novel 3D imaging of the amplitudes (dB) against time 
(micro-second) that was the depth of the sample at a particular frequency using the flat-bed 
scanner, which was a computerised system that produced consistent data in three dimensions.   
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Figure 4.24: Frequency-time analysis at different frequencies (0.5 MHz, 1:5 MHz) of a 
cylindrical disc sample (with circle holes at edges) using Echo-Pulse Ultrasound Transducer 
(2.25 MHz). Please note that z is depth (time), x is transducer position (1:160) and y is 
transducer elements (1:124). 
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4.7. Validation of Novel BUA Method Using Breast Phantom  
Using Olympus’ industrial ultrasound inspection unit, the Omniscan, with a 128 element 2.25 
and 5 MHz phased-array transducer and a commercial breast phantom which had six solid 
and cystic masses with ultrasound attenuation coefficients of 0.1–1.5 dB/MHz/cm in 
frequency range of 2–10 MHz [81], 3D data of the breast phantom in A-scan (Amplitude 
scan) was obtained. First, STFT of the signals was obtained by computing the Fourier 
transform of sliding a time analysis window using MATLAB spectrogram. This STFT is 
amplitude against time (micro second) analysis at a particular frequency. Second, reference 
amplitude components would then be chosen by determining the maximum amplitude 
component from each signal and incorporating it into the program in order to calculate 
attenuation coefficients (dB) at a particular frequency. Five programs for attenuation 
coefficients were performed at five different frequencies 0.5, 1, 1.5, 2 and 2.5 MHz. Finally, 
the regression analysis for estimating the relationship between the attenuation coefficients 
(dB) and frequencies (MHz) was performed in order to determine the slope that is broadband 
ultrasound attenuation BUA (dB/MHz). Finally, the 3D BUA (dB/MHz) mapping of breast 
phantom was formed based on overlaying of QUS parameter of BUA slope.  
4.7.1. 3D BUA of Breast Phantom Using 2.25 MHz Broadband Transducer 
Figure 4.25 shows novel 3D BUA (dB/MHz) of six breast lesions. The locations of these 
breast lesions are same as in Figures 4.16 and 4.18. This novel 3D BUA (dB/MHz) of six 
solid lesions was formed based on overlaying of BUA value of 7.16 dB/MHz. It has been 
reported that the BUA for such a solid breast lesion falls in the range of 0.1-1.5 dB/MHz/cm, 
i.e.  0.9-13.5 dB/MHz [81]. For the present experiment a number of different BUA values 
have been tried in this range, but the BUA value of 7.2 dB/MHz was found to be most 
appropriate in terms of quality of the image generated. Based on this, the BUA to form 3D 
BUA image of solid breast lesions was arbitrarily set in this experiment to a value of 7.2 
dB/MHz.  Figure 4.26 shows that the nBUA within the solid masses at a region of 
(101:105,60,12) was (0.74 +/- 0.09) dB/MHz/cm, since 0.74 is average nBUA and 0.09 is 
standard deviation for five measurements. Note that 101:105 is transducer position (slices), 
60 is transducer element and 12 is time (the depeth of time). This solid lesion was in red 
colour at a depth of 12 (= 4.73 cm). The depth of 12 is equal to 4.73 cm, since 6.14e-5s 
(depth time) * 1540 m/s (speed of sound) * 1/2 (path twice) is equal to 4.73 cm. The nBUA 
was the BUA divided by the thickness of the phantom, which was 9 cm. All BUA values 
were divided by 2 because the pulse of ultrasound travelled into the phantom and returned to 
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the transducer. The measurements were performed over a range of frequencies from 0.5–2.5 
MHz using a transducer with a centre frequency of 2.25 MHz. In addition, the large area that 
was in red colour showed the solid mass with higher value of BUA (dB/MHz) (Figure 4.26), 
while Figure 4.27 shows that the nBUA had (0.51 +/- 0.09), since 0.51 is average nBUA and 
0.09 is standard deviation for five measurements. This region indicated the cystic mass (filled 
fluid mass) with small size in red colour and smaller BUA values due to less attenuation. The 
cystic lesion had two regions, one of them had a very small area that had high attenuation 
(please see figure 4.13). This red colour was due to the very small area. 
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Figure 4.25: Novel 3D BUA image of six breast lesions at 2.25 MHz, the nBUA (7.16 
dB/MHz * (½ (path twice) / 9 cm (thickness of the sample)) 0.39 dB/MHz/cm. The image 
was formed based on overlaying of BUA value of 7.16 dB/MHz. These six lesions indicate 
the solid masses (in yellow colour) with high value of BUA. The z axis is depth, y axis is 
slices or transducer positions and x axis is the transducer elements. Transducer positions from 
0 to 160 are related to 0 to 160 mm, transducer elements (1:4:124) corresponds to 99 mm, 
and depth values (5:20) corresponds to 98 mm.  
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Figure 4.26: 3D BUA map of breast phantom at 2.25 MHz, the nBUA at a region (1) of 
101:105,60,12 is (0.74 +/- 0.09), since 0.74 is average nBUA and 0.09 is standard deviation 
for five measurements. The nBUA of a region (2) of 63:67,80,12 is (0.55 +/- 0.04) 
dB/MHz/cm. These regions (1 and 2) indicated the solid masses (in red colour) with high 
value of BUA. Please note that 101:105 is transducer positions (slices), 60 is transducer 
element and 12 is time (depth of time). Transducer positions from 0 to 160 are related to 0 to 
160 mm, transducer elements (1:4:124) corresponds to 99 mm, and depth values (5:20) 
corresponds to 98 mm.  
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Figure 4.27: 3D BUA map of breast phantom at 2.25 MHz, the nBUA at a region of 
105,31:35,6 is (0.51 +/- 0.09), since 0.51 is average nBUA and 0.09 is standard deviation for 
five measurements. This region indicated the cystic mass (filled fluid mass) with small size in 
red colour. Please note that 105 is transducer position, 31:35 is transducer elements and 6 is 
time (depth of time). Transducer positions from 0 to 160 are related to 0 to 160 mm, 
transducer elements (1:4:124) corresponds to 99 mm, and depth values (5:20) corresponds to 
98 mm. There are some features at the sides around the phantom and from the top of the 
water surface due to reflection that need to be neglected. 
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4.7.2. 3D BUA of Breast Phantom Using 5 MHz Broadband Transducer 
The BUA measurements were performed using a transducer with a centre frequency of 5 
MHz over a range of frequencies from 1–5 MHz. Figure 4.28 showed that nBUA within the 
solid masses at a region of 101:105,60,12 was (0.34 +/- 0.08), since 0.34 is average nBUA 
and 0.08 is standard deviation for five measurements. Note that 101:105 is transducer 
positions (slices), 60 is transducer element and 12 is time (depth of time). The normalised 
BUA was the BUA divided by the thickness of the phantom, which was 9 cm. All BUA 
values were divided by 2 because the pulse of ultrasound travelled into the phantom and 
returned to the transducer. The 5 MHz transducer showed that the nBUA within the solid 
lesion had a lower value than the 2.25 MHz transducer, since (0.34+/- 0.08) dB/MHz/cm 
against (0.74 +/- 0.09) dB/MHz/cm at the same region (1) (see Table 4.3). On the other hand, 
the 5 MHz transducer was unable to detect the cystic masses at different depths in the 
phantom. The cystic masses disappeared in Figure 4.29 (the image on the right side) due to 
strong attenuation.  
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Figure 4.28: 3D BUA map of breast phantom at 5 MHz, the nBUA at a region (1) of 
101:105,60,12 is (0.34 +/- 0.08), since 0.34 is an average nBUA and 0.08 is standard 
deviation for five measurements. The nBUA of a region (2) of 63:67,80,12 is (0.25 +/- 0.09) 
dB/MHz/cm. These regions (1 and 2) indicated the solid masses (in red colour) with high 
value of BUA and bright red colour. Please note that 101:105 is transducer positions (slices), 
60 is transducer element and 12 is time (depth of time). Transducer positions from 0 to 160 
are related to 0 to 160 mm, transducer elements (1:4:124) corresponds to 99 mm, and depth 
values (5:20) corresponds to 98 mm.  
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Table 4.3 : A very good agreement between the expected BUA and measured BUA for 
two transdcuers , where 5 MHz transducer having bandwidth approximately from 0.5 
to 8.5 MHz.  
Transducer 
(MHz) 
Solid Lesion 
Expected BUA (dB/MHz/cm) 
within 2 to 10 MHz 
Measured BUA (dB/MHz/cm) 
2.25 
First From 0.1 to 1.5  0.74 +/- 0.09 
Second From 0.1 to 1.5  0.55 +/- 0.04 
5 
First From 0.1 to 1.5  0.34 +/- 0.08 
Second From 0.1 to 1.5  0.25 +/- 0.09  
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Figure 4.29: 3D BUA analysis of cystic lesions, in the upper image. The analysis showed 
cystic lesions using the 2.25 MHz transducer. In the lower image, the cystic lesion 
disappeared when using the 5 MHz transducer at the same depth due to strong attenuation. 
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Chapter 5:  
Discussion 
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5. Introduction  
This chapter discusses the implications of the results of the analysis of the spatial resolution, 
3D spatial accuracy of the flat-bed scanner and 3D BUA map of breast phantom presented in 
Chapter 4. The main purpose of this research is to develop a novel quantitative 3D ultrasound 
measurement technique that is based upon the variable-frequency ultrasound system. The 
important contribution of this technique is image and signal processing of the ultrasound data 
using MATLAB development platform, which can be used to differentiate cystic lesions from 
solid lesions. Specifically, the development and scientific validation of the novel 3D BUA 
software that can be used by the user to classify breast lesions. This system allows the 
acquisition of 3D ultrasound data of the tissue and displays the data in different formats as A-
scan and B-scan. Each model allows differents ways of evaluating the region of the tissue 
scanned. The second important development component of the flat-bed ultrasound scanner is 
the scanning tank, which when placed in a water bath will provide a means of reliable 
ultrasound coupling and a flexible mesh that supports for the sample.  
5.1. Spatial Resolution of the Flat-bed Scanner  
The general purpose multi-tissue ultrasound phantom was scanned by the flat-bed scanner 
using 2.25 and 5 MHz transducers to study the spatial resolution of the flat-bed scanner. The 
results of the 2.25 MHz transducer showed some near field circles, axial and lateral 
resolution, deep circles and cystics. The results of the 5 MHz transducer showed a more clear 
image of near field circles and better axial and lateral resolution. The 5 MHz transducer could 
distinguish between close objects with clear strong echoes much better than the 2.25 MHz 
transducer, using the general purpose multi-tissue ultraosund phantom. It was noticed that the 
5 MHz transducer showed better spatial resolution for several features of the phantom such as 
near field circle, axial and lateral resolution, deep circles and cystics, compared with the 2.25 
MHz transducer. In addition, It was noted that the 2.25 MHz transducer showed more deep 
penetration ultrasound due to lower frequency that showed more information on deep near 
field objects and deep cystic objects.  
 
The wire phantom was also used to study the spatial resolution of the flat-bed ultrasound 
scanner utilising broadband transducers that incorporate both high frequency (high 
resolution) and lower frequency (deep penetration). This phantom, which was home-built, 
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had dimensions of 85 mm length x 45 mm width x 10 mm height. The resolutions of the 3D 
data were 1 mm length (lateral) x 1 mm width x 0.308 mm height (axial). The resolution of 
the transducer elements was chosen to be 1 mm. The resolution between the images, 1 mm, 
depended on the resolution of the transducer elements and the speed of the scanner, which 
was 1 mm/s. The resolution in the height dimension was 0.308 mm, depending on the sample 
points and the depth of the sample in mm. The spatial resolutions of the data were provided 
by the Ominscan device and were taken into account when the data was transferred into the 
Simpleware. 
Two 3D models of the wire phantom were generated using two 2.25 and 5 MHz phased-array 
transducers to prove and validate the spatial accuracy of the flat-bed ultrasound scanner. The 
ScanIP 3D measurement tool was used to measure the distance between points in 3D view 
using a line with arrow heads at either end. The arrow heads could be dragged and the entire 
model could be spanned. The distance between the arrow heads was shown to determine the 
distance between points in mm. The measured values of dimensions of the wire phantom in 
length (x), width (y) and height (z) confirmed the reliability and repeatability of the spatial 
resolution of the proposed flat-bed ultrasound scanner. The results of the measured values of 
the wire dimensions for 2.25 MHz array transducers were (84.72 +/- 0.09) mm (x), (44.8 +/- 
0.19) mm (y) and (10.06 +/- 0.11) mm (z). In addition, the measured values of the wire 
dimensions for 5 linear-array transducers were (84.85 +/- 0.11) mm (x), (44.99 +/- 0.11) mm 
(y) and (9.99 +/- 0.14) mm (z). The dimension measurements were repeated five times to 
determine the standard deviation. In addition, the wire phantom had a rectangular shape and 
20 wires in two groups; each group had 10 wires which were positioned systematically. The 
distance between two groups ranged from 1 mm to 10 mm in height. The measured values 
also confirmed the systematic shape of the wire phantom.  
In order to investigate the reliability and repeatability of the flat-bed ultrasound scanner in 
terms of spatial resolution, the GE Voluson ultrasound scanner, a state-of-the-art medical 
device, was utilised with the GE 11 MHz linear transducer. The resolutions of 3D data were 
0.169 mm (axial) x 0.169 mm x 0.5 mm (lateral). The total measured length, width (y) and 
height were (84.60 +/- 0.43) mm x (44.90 +/- 0.15) mm x (9.91 +/- 0.19) mm, respectively. 
The calculations were repeated five times to determine the standard deviation. The measured 
values of the dimensions of the wire phantom confirmed the reliability and repeatability of 
the flat-bed ultrasound scanner. However, the axial and lateral resolutions of the GE Voluson 
were better than the flat-bed scanner, since the axial and lateral resolution were 0.17 mm and 
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0.5 mm against 0.31 mm and 1 mm, respectively, as expected because of the higher 
frequency of the 11 MHz linear transducer.  
The resolution of the flat-bed pulse-echo ultrasound scanner could be affected by several 
parameters, including the transducer, the centre frequency of the beam, bandwidth of the 
beam and the beam width. The 128-element linear-array transducer was utilised with specific 
resolution between each the elements in the arrays to achieve specific interference patterns, 
which produced a narrow ultrasonic beam, having a source beam width of approximately 100 
mm, which could be focused at upto a 100 mm depth in tissue. Both transducers had the same 
beam width (100 mm) and bandwidth (0.5-4.5 MHz for 2.5 MHz transducer). The spatial 
resolutions of this 3D data were 1 mm length x 0.308 height mm x 1 width mm. The axial 
resolution was approximately 0.308 mm. The flat-bed scanner could resolve two objects, one 
above the other, along the ultrasound beam, with the distance between the objects as small as 
1 mm. For distances smaller than 0.308 mm, the objects appeared to merge in the image and 
could not be resolved. On the other hand, lateral resolution was 1 mm. The system could 
resolve two objects that lay side by side when the beam was scanned across the object, but 
the image of the object blurred due to the beam width, which was approximately 10 mm.  
5.2. 3D Spatial Accuracy of the System Using Breast Phantom 
The previous methodology was used to collect 3D data of the breast lesions using 2.25 and 5 
MHz transducers with resolutions of 1 mm (lateral) x 0.308 mm (axial) x 1 mm. The 
segmentation was performed on a breast phantom containing solid and cystic lesions. 
Different colours were assigned to all masks for different solid lesions. The GE Voluson 
scanner was used in order to investigate the reliability of the flat-bed scanner and to compare 
these solid lesions correctly with solid lesions obtained by using the flat-bed scanner to 
determine the measured volumes (mm
3
), shapes and locations of the solid mass. The 
measured volumes using the 2.25 MHz linear transducer and the flat-bed scanner were as 
follows: the purple solid lesion had a volume of (1.64 x 10
3
 +/- 12.6) mm
3
, the brown solid 
lesion had a volume of (946 +/- 19.7) mm
3
, the blue solid lesion had a volume of (1.65 x 10
3
 
+/- 20.6) mm
3
, the green solid lesion had a volume of (2.40 x 10
3
 +/- 21.7) mm
3
, the bright 
green solid lesion had a volume of (655 +/- 12.1) mm
3
 and the red solid lesion had a volume 
of (1.63 x 10
3
 +/- 11.4) mm
3
. Similar volumes for solid lesions were obtained using the 5 
MHz transducer. The measured volumes in mm
3
 using the 11 MHz Voluson linear-array 
transducer are as follows: the purple solid lesion had a volume of (1.64 x 10
3
 +/- 18.6) mm
3
, 
the brown solid lesion had a volume of (942 +/- 33.1) mm
3
, the blue solid lesion had a 
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volume of (1.62 x 10
3
 +/- 40) mm
3
, the green solid lesion had a volume of (2.42 x 10
3
 +/- 
17.6) mm
3
, the bright green solid lesion had a volume of (651 +/- 29.5) mm
3
 and the red solid 
lesion had a volume of (1.64 x 10
3
 +/- 24.4) mm
3
. Although the measurements were 
performed on the inverted breast phantom using the flat-bed scanner and different frequency 
transducers, compared with the GE Voluson scanner, similar results were obtained regarding 
lesion volumes. These results further confirmed the 3D spatial accuracy of the flat-bed 
ultrasound scanner. However, there were differences in location and shape of breast lesions, 
which was due to the different orientation of the breast lesions. This was because the flat-bed 
scanned inverted (upside-down) breast phantom, while the Voluson scanned normal breast 
phantom from the top of the phantom. It would be good if the flat-bed could scan normal 
breast phantom from the top or Voluson scanned from bottom since patients would be 
scanned using flat-bed orientation. Apart from these differences, the experimental study 
demonstrated that the flat-bed could accurately diagnose breast lesions. It also validated 
lesion identification compared to the GE Voluson. Overall, the performance between the flat-
bed scanner and the GE Voluson scanner is similar in terms of detecting and measuring the 
volumes of the solid masses using breast phantom from CIRS. Also, there are different 
performances between the flat-bed and GE Voluson scanner in terms of detecting masses; the 
qualitative image of the flat-bed for the cystic lesion showed only a very small area with high 
attenuation, but the GE Voluson image of the cystic lesion showed a large area with low 
attenuation and a very small area with high attenuation. However, the flat-bed pulse-echo 
ultrasound scanner was able to image solid masses with thickness of 8–12 mm embedded in 
tissue-equivalent material. The axial and lateral resolutions were 0.308 mm and 1 mm, 
respectively. Some of the segmented data of the solid lesions that were obtained from the two 
different methods do not have very smooth shapes due to the noise from the random variation 
in signal amplitude measurements of detected echoes [3]. 
            
5.3. Validation for 3D BUA Characterisation of Breast Phantom Using 2.25 and 5 MHz 
Broadband Transducers 
The commercial breast phantom from the CIRS was used to calculate the broadband 
ultrasound attenuation (dB/MHz), and the normalised BUA (dB/MHz/cm) was subsequently 
calculated by dividing the BUA by the thickness of the phantom (9 cm). The BUA 
measurements were performed with two broadband transducers. This phantom had 
attenuation coefficients of 0.1–1.5 dB/MHz/cm in frequency range of 2–10 MHz with the 
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velocity of ultrasound of 1540 m/s. The linear regression slopes (dB/MHz) were obtained to 
calculate the nBUA (dB/MHz/cm). The calculated nBUA values of 0.25–0.74 dB/MHz/cm 
were obtained within breast lesions and were in agreement with the attenuation coefficients 
(dB/MHz/cm), which were between 0.1 and 1.5 dB/MHz/cm in a frequency range of 2–10 
MHz. The results of the calculated nBUA have proved the repeatability of the novel 
technique using two linear transducers. The calculated nBUA values were obtained within the 
breast lesions. In addition, this analysis validated the time required by the signals to emit into 
the phantom and return, as a result of which the thickness of the phantom was calculated as 9 
cm. This implies that the quantitative BUA methodologies were reliable and reproducible.   
Important results were obtained when looking at the frequency dependence of the attenuation 
coefficients. It was noted that the BUA analysis produced linear frequency dependent 
attenuation in the breast phantom. The attenuation varied linearly with frequency in the 
frequency ranges of 0.5–2.5 MHz and 1:5 MHz for 2.25 and 5 broadband transducers, 
respectively. In addition, it was found that the nBUA (dB/MHz/cm) had higher values 
associated with red colour in solid masses, and these quantitative values were in agreement 
with the patent documentation [81]. For example, nBUA (slope) value in the breast phantom 
(solid masses) was 0.74 +/- 0.09 dB/MHz/cm, associated with red colour, while cystic masses 
were 0.51 +/- 0.09 dB/MHz/cm at 2.25 MHz, associated with bright red colour in the 
frequency bandwidth of 0.5–2.5 MHz. Typically, these nBUA for cystic masses were 
obtained from the solid/semi-solid material of the lesion, not the fluid material, as this novel 
BUA technique is very sensitive to solid materials. The cystic lesions had thicknesses of 8–15 
mm, while the solid lesions had thicknesses of 6–12 mm. The 3D BUA mapping of the breast 
phantom using a 2.25 MHz multi-frequency transducer showed that the cystic lesions had 
smaller thickness than the thicknesses of the solid lesions, although the cystic masses had 
larger sizes; this was expected because the cystic lesions were softer than the solid masses. 
Also, the 5 MHz multi-frequency transducer characterised the solid masses, but the cystic 
masses did not appear in the BUA mapping of the breast lesions. The BUA analysis could not 
detect the cystic masses due to the high attenuation of the 5 MHz transducer. Also, it was 
noted that BUA analysis detected the lesions that could cause high attenuation of the signal, 
such as solid lesions. This means that BUA analysis could detect only solid lesions that cause 
high attenuation the ultrasound signal.  
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5.4. Implementation of Quantitative 3D Broadband Ultrasound Technique  
The flat-bed scanner was designed and built in order to carry out phantom experiments to 
study spatial resolution and 3D BUA analysis. Data could be collected with the scanner with 
one linear-array transducer of length 100 mm, or perhaps of length 300 mm that can scan 
both breasts within a single lateral sweep (Figure 5.1). 3D BUA program was developed and 
utilised to construct 3D mapping BUA of breast lesions. This BUA technique could be 
incorporated into the flat-bed scanner. Practically, we believe that the patient will be required 
to sit or lie face down to house her breasts for the data to be acquired (Figure 5.1). This 
process will take approximately 3 minutes to scan a whole breast with a 10 cm depth of field 
and an extra time of 20 minutes for 3D BUA mapping of both breasts. Volume measurement 
of breast lesions will take longer because the data are acquired in 2D planes, which need to be 
reconstructed into 2D ultrasound images using MATLAB and stacked to create a 3D model 
of breast lesions using Simpleware software.  
 
Figure 5.1: The conception of a clinical system of quantitative 3D broadband ultrasound 
technique.  
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6. Conclusion 
The quantitative ultrasound (QUS) methodologies discussed in this paper seem to be an ideal 
method for measuring breast lesions, because they are relatively inexpensive, portable, non-
ionising and flexible. Using Olympus’ industrial ultrasound inspection unit, the Omniscan, 
with 128-element 2.25 and 5 MHz broadband transducers, has demonstrated that a 
commercial breast phantom from CIRS can be imaged successfully in approximately three 
minutes. Additionally, the same hardware has been used to create a novel software of a 3D 
attenuation map for the breast phantom. The BUA values obtained from the attenuation map 
were comparable to values found in the patent documention for the phantom from CIRS (0.1–
1.5 dB/MHz/cm) [81]. The calculated nBUA values were within the range of 0.25–0.74 
dB/MHz/cm in the frequency range of 0.5–5 MHz. The qualitative imaging and quantitative 
attenuation characterisation of breast lesions in this project are milestones in the lead up to 
the development of a pulse-echo ultrasound scanner capable of providing clinically relevant 
information on the status of breast cancer. Also, the 3D data has been collected successfully 
using the flexible mesh for coupling instead of using the conventional gel. 
The pulse-echo method proposed for use in this practical experimentation is based on 
quantitative techniques that measure sound wave amplitudes to produce signals. 2D 
amplitude A-scan and B-scan of the phantom have been collected successfully from the 
Omniscan. 3D data (124 elements x 4000 time points x 200 slices (images)) of A-scan have 
been acquired successfully in this technique. A-scans with digitising frequency (e.g. 25 MHz) 
and subsequently different time points have been acquired to determine the time-frequency 
study and BUA measurements in the phantom using MATLAB. The MATLAB spectrogram 
signal processing tool can be used to examine specific data and establish the concepts of 
BUA measurement. The MATLAB spectrogram could create 3D (time in micro second x 
slices x elements x colour coded for amplitude) images of the phantom. The signal processing 
technique proved accurate in determining the BUA measurement and in ensuring the 
repeatability of the system. The nBUA values of the breast solid lesion for the 2.25 and 5 
MHz transducers were 0.74 +/- 0.9 dB/MHz/cm and 0.51 +/- 0.09 dB/MHz/cm, respectively, 
for the same solid lesion. It was expected that nBUA has lower value as the frequency 
increases. This is of great importance, especially in work that is required to investigate 
minute details of a breast phantom.  
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Promising results were obtained for the differentiation of solid/malignant from cystic/benign 
lesions. Experimental results using a tissue mimicking phantom demonstrated the accuracy of 
the novel BUA analysis based on the short time Fourier transform (time-frequency analysis) 
to determine BUA. Experimental nBUA values obtained using the breast phantom were 
within the range of 0.25–0.74 dB/MHz/cm in the frequency range of 0.5–5 MHz, and in a 
good agreement with values within the range of 0.1–1.5 dB/MHz/cm in the frequency range 
of 2–10 MHz found in subjects [81]. This result confirmed the accuracy and repeatability of 
the 3D BUA technique. The 3D BUA data were shown in colour-coded BUA: the lesion had 
higher BUA that was in red colour, and normal tissue had lower BUA that was in yellow 
colour. Accurate estimation of BUA could provide useful diagnostic information and would 
enable better interpretion of conventional ultrasound images, since the BUA analysis can 
detect only solid lesions that cause high attenuation to signal.  
The conventional B-mode sonographical images are mostly qualitative. The methodology 
proposed in this study proved to be capable of allowing the acquisition of the entire volume 
of data from a single scan and simultaneously enabling both A-scan and B-scan. The flat-bed 
scanner proved to produce three-dimensional data that could be processed to create a 3D 
image of the phantom. The data collected during a scan was successfully imported into 
Simpleware software that could be used to differentiate cysts from solid lesions. The 
Simpleware also demonstrated that it was able to provide a complete 3D ultrasound 
representation of the phantom scanned. Spatial resolution and 3D spatial accuracy of the flat-
bed scanner were established and compared with different experiments using the GE Voluson 
scanner.  
Experimental results showed that the 5 MHz transducer had better spatial resolution than the 
2.25 MHz transducer, which had deeper ultrasound penetration using the general purpose 
multi-tissue ultrasound phantom. Experimental results showed that the flat-bed scanner was 
better in terms of resolution and penetration than the GE Voluson scanner. The flat-bed 
scanner utilising the phased-array broadband transducer maintained the advantages of the 
high spatial resolution of the higher frequency and the deeper tissue penetration of the lower 
frequency, thereby improving image quality. As the GE Voluson could only operate at one 
frequency, the axial and lateral resolutions of GE scanner were better than the flat-bed 
scanner, since the axial and lateral resolution were 0.17 mm and 0.5 mm against 0.31 mm and 
1 mm, respectively. The measured length, width and height were (84.60 +/- 0.43) mm x 
(44.90 +/- 0.15) mm x (9.91 +/- 0.19) mm, respectively, using the GE 11 MHz transducer. 
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The measured values of the wire dimensions for the 2.25 MHz array transducers were (84.72 
+/- 0.09) mm (length), (44.8 +/- 0.19) mm (width) and (10.06 +/- 0.11) mm (height). The 
calculations were repeated five times to determine the standard deviation. The measured 
values of the dimensions of the wire phantom confirmed the reliability and repeatability of 
the flat-bed ultrasound scanner.  
In additon, the initial GE Voluson validation of the flat-bed scanner showed that the flat-bed 
scanner is sensitive to similar structures as the GE Voluson, and the study demonstrated that 
the flat-bed scanner could accurately map breast lesions, thereby allowing direct volume 
measurement to be performed. Also, comparison with the GE Voluson can validate the 
identification of breast lesions with the flat-bed scnner. The calculated volumes were as 
follows: the purple solid lesion had a volume of (1.64 x 10
3
 +/- 12.6) mm
3
, the brown solid 
lesion had a volume of (946 +/- 19.7) mm
3
, the blue solid lesion had a volume of (1.65 x 10
3
 
+/- 20.6) mm
3
, the green solid lesion had a volume of (2.40 x 10
3
 +/- 21.7) mm
3
, the bright 
green solid lesion had a volume of (655 +/- 12.1) mm
3
 and the red solid lesion had a volume 
of (1.63 x 10
3
 +/- 11.4) mm
3
, using the 2.25 MHz linear transducer and flat-bed scanner. The 
calculated volumes in mm
3
 using the 11 MHz Voluson linear-array transducer were as 
follows: the purple solid lesion had a volume of (1.64 x 10
3
 +/- 18.6) mm
3
, the brown solid 
lesion had a volume of (942 +/- 33.1) mm
3
, the blue solid lesion had a volume of (1.62 x 10
3
 
+/- 40) mm
3
, the green solid lesion had a volume of (2.42 x 10
3
 +/- 17.6) mm
3
, the bright 
green solid lesion had a volume of (651 +/- 29.5) mm
3
 and the red solid lesion had a volume 
of (1.64 x 10
3
 +/- 24.4) mm
3
. 
In regard to the research questions and according to the results mentioned in this chapter, a 
quantitative 3D ultrasound technique based on a variable-frequency ultrasound can be 
developed and scientifically validated to provide more information, such as broadband 
ultrasound attenuation (dB/MHz/cm) assessment of breast lesions in addition to the volume 
of breast lesions, unlike the clinical ultrasound scanner, which provides a single qualitative 
image. Also, software can be developed that can be used by the user to classify different 
types of breast lesions based on 3D BUA mapping of breast lesions.  
The third research question, yes there is a linear relationship between attenuation (dB) and a 
range of frequencies (MHz) for breast tissue. Since the breast phantom consists of tissue-
mimicking materials that accurately replicate the ultrasonic characteristics (i.e. attenuation & 
velocity of sound), it is envisaged that similar findings would be observed in natural breast 
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tissues. Since the solid elastic material has a speed of sound within the range of of 1420 m/s 
to 1650 m/s and a sonic attenuation within the range of 0.1 to 1.5 dB/MHz/cm in the 
frequency range of 2 to 10 MHz. It has been found that the attenuation has a linear 
relationship with a particular range of frequencies. For example, the attenuation within a solid 
lesion increases when frequency increases from 0.5 up to 2.5 MHz for 2.25 MHz transducer. 
The slope of the line is 0.74 +/- 0.09 dB/MHz/cm. Since 0.74 is average nBUA and 0.09 is 
the standard deviation.     
This research is not only timely but also of great significance in medical imaging and medical 
diagnosis in general. Therapeutic and diagnostic medical imaging is of benefit to both 
patients and medical practitioners through more rapid and precise management of disease, 
fewer side effects and better outcome.  
 
This research is expected to enhance a fundamental understanding of Broadband Ultrasound 
Attenuation and investigative diagnosis of breast cancer from testing the suitability of the 
proposed pulse-echo ultrasound system.  
If the proposed method is found to raise the level of accuracy and improve the scope of 
diagnosis as expected, this research will increase the body of knowledge in medical imaging 
and improve ultrasound imaging to a level where it can be more reliable and useful. This 
study has the potential to change and improve ultrasound medical imaging practices by 
raising the standards of quality.  
6.1. Limitations of the Work and Further Directions 
As mentioned, mammography breast cancer imaging methods can diagnose solid lesions 
(ductal carcinoma in situ (DCIS)) as small as 2 mm in diameter [3]. It would be beneficial if 
we could have used, in this research, a breast phantom with solid lesions of this thickness. It 
would be interesting to study the validation of the 3D BUA mapping technique described in 
this project for a phantom with solid masses of approximately 2 mm thickness. This would be 
expected to provide more comparable results as far as mammography is concerned and also 
to widen the scope of this novel technique in breast cancer diagnosis. It also would be 
interesting to study the validation of the 3D BUA mapping technique for a real breast with 
lesions. This could be expected to provide more explanation and to determine whether breast 
lesion is solid or cystic.  
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One significant limitation of this research was that the exact locations of the lesions within 
the breast phantom were unknown; this could be addressed in the future by comparison with 
MR imaging of the phantom. 
This research has not clinically validated the Quantitative 3D Ultrasound system, this might 
possibly be done by studying individuals with known pathology and comparing the outcomes 
with other established techniques such as mammography.  
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8. Appendix  
8.1 MATLAB Software 
 
% Software for Broadband Ultrasound Attenuation (BUA) Calculations  
% This software reads an ultrasound signals from a file and calculates the 
short-time Fourier Transform (STFT) for all signals in 3D dimensions 
a = load('.txt', '-ascii'); % load file with your filename 
nSlices = 171; % Number of slice (transducer positions) 
nTdVectors = 124; % Number of transducer element 
nTdPoints =3180; % Number of points per each time domain vector 
 b = reshape(a,nSlices, nTdVectors, nTdPoints); % reshape to 3D data 
 s_window = 256;  % Sliding window length 
 s_overlap = s_window/2; % Windows overlapping length 
 samp_freq = 25e6;  % Sampling frequency 
% Create frequencies distribution 
% N_freq = 5 % Number of frequencies to look at 
  Fs = 1e6*[0.5,1,1.5,2,2.5];  %from 0.5 Mhz to 2.5 Mhz, as required 
  
% Check the matrix sizes we need 
  dt1 = reshape(b(1,:,:),nTdVectors,nTdPoints); 
   [slice2d,F,T]= (spectrogram(dt1(1,:),s_window,s_overlap,Fs,samp_freq)); 
% Now F contains frequency scale, T contains time scale, with appropriate  
     units 
   sFreq_domain = length(F); % Number of frequencies 
   sTime_domain = length(T); 
  
im3dout_05 = zeros(nSlices,nTdVectors,sTime_domain); % Prepare final 
matrixes 
im3dout_1 = im3dout_05; % for 1 MHz 
im3dout_1_5 = im3dout_05; % for 1.5 MHz 
im3dout_2 = im3dout_05;% for 2 MHz 
im3dout_2_5= im3dout_05;% for 2.5 MHz 
for j = 1:171  % Loop over slices - nSlices 
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data3d = zeros(nTdVectors,sFreq_domain,sTime_domain); %Prepare temporal 
data for 2D slice 
 dt1 = reshape(b(j,:,:),nTdVectors,nTdPoints);  % Get current slice 
 
% Loop over spectrograms - nTdVectors 
for i=1:124       [slice2d,F,T]= 
(spectrogram(dt1(i,:),s_window,s_overlap,Fs,samp_freq)); 
        data3d(i,:,:) = abs(slice2d);   
      %  i % show current spectrogram index 
end 
 
% To select frequency components 
frequim3dout_05(j,:,:) = data3d(:,1,:); % get the 0.5 MHz component from 
spectrogram 
im3dout_1(j,:,:) = data3d(:,2,:); % get the 1 MHz component from 
spectrogram 
im3dout_1_5(j,:,:) = data3d(:,3,:); %get the 1.5 MHz component from 
spectrogram 
im3dout_2(j,:,:) = data3d(:,4,:); %get the 2 MHz component from spectrogram 
im3dout_2_5(j,:,:)= data3d(:,5,:); %get the 2.5 MHz component from 
spectrogram 
  
j % show current slice index 
end 
% get sizes 
sizeX = size(im3dout_05,1); 
sizeY = size(im3dout_05,2); 
sizeZ = size(im3dout_05,3); 
 
% Determing the reference signal (the maximum amplitude) from each 
transducer element 
% and divided over all points for specific transducer element points in 
oreder to determine the attenuation coefficients for every frequency  
 
t2 = max(max(im3dout_05,[],3),[],1); %0.5 MHz 
diffarr = im3dout_05./repmat(t2,[sizeX 1 sizeZ]); 
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att_coeff_1_MHz = (20*log10(diffarr)); 
  
t2 =max(max(im3dout_1,[],3),[],1); % 1 MHz 
diffarr = im3dout_1./repmat(t2,[sizeX 1 sizeZ]); 
att_coeff_2_MHz = (20*log10(diffarr)); 
  
t2 =max(max(im3dout_1_5,[],3),[],1);% 1.5 MHz 
diffarr = im3dout_1_5./repmat(t2,[sizeX 1 sizeZ]); 
att_coeff_3_MHz = (20*log10(diffarr)); 
  
t2 =max(max(im3dout_2,[],3),[],1);% 2 MHz 
diffarr = im3dout_2./repmat(t2,[sizeX 1 sizeZ]); 
att_coeff_4_MHz = (20*log10(diffarr)); 
  
t2 =max(max(im3dout_2_5,[],3),[],1); % 2.5 MHz 
diffarr = im3dout_2_5./repmat(t2,[sizeX 1 sizeZ]); 
att_coeff_5_MHz = (20*log10(diffarr)); 
 
 
% Assumes the workspace contains variables from processing script. 
% It should have 3D volume for each desired frequency 
% Regression calculations between attenuation coefficients and five 
frequencies 
x = [0.5,1,1.5,2,2.5]; %X -axes MHz - multiply by 1e6 if requered 
dsize = size(att_coeff_1_MHz); 
  
% Allocate output matrixes 
matOffset = zeros(dsize); % Offset 
matSlope = zeros(dsize); %Slope 
matError = zeros(dsize); % Error 
matMean = zeros(dsize); % Mean 
matStd = zeros(dsize); % Standard deviation 
% Do the regression,point by point 
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for ix =1:dsize(1) 
    for iy = 1:dsize(2) 
        for iz =1:dsize(3) 
% Every point comes from the different 3D volume 
y = [att_coeff_1_MHz(ix,iy,iz)... 
    ,att_coeff_2_MHz(ix,iy,iz)... 
    ,att_coeff_3_MHz(ix,iy,iz)... 
    ,att_coeff_4_MHz(ix,iy,iz)... 
    ,att_coeff_5_MHz(ix,iy,iz) ];             
             
[p,S,mu] = polyfit(x,y,1); 
matOffset(ix,iy,iz) = p(2); 
matSlope(ix,iy,iz) = p(1); 
matError(ix,iy,iz) = S.normr; 
matMean(ix,iy,iz) = mu(1); 
matStd(ix,iy,iz) = mu(2); 
  
        end 
    end 
    ix 
end 
 
% Finally display the 3D BUA (dB/MHz) map of a phantom via matslope (slope 
(BUA)) using GUI (sliceomatic) 
 
 sliceomatic(matSlope); 
 
 
 
 
